CA2820419A1 - Agents and methods for inhibiting human pluripotent stem cell growth - Google Patents

Info

Publication number

CA2820419A1

CA2820419A1 CA2820419A CA2820419A CA2820419A1 CA 2820419 A1 CA2820419 A1 CA 2820419A1 CA 2820419 A CA2820419 A CA 2820419A CA 2820419 A CA2820419 A CA 2820419A CA 2820419 A1 CA2820419 A1 CA 2820419A1

Authority

CA

Canada

Prior art keywords

cells

cell

pluripotent stem

differentiation

differentiating

Prior art date

2010-12-08

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 287
• 210000001778 pluripotent stem cell Anatomy 0.000 title claims abstract description 164
• 230000010261 cell growth Effects 0.000 title claims abstract description 18
• 230000002401 inhibitory effect Effects 0.000 title abstract description 60
• 210000004027 cell Anatomy 0.000 claims abstract description 903
• 239000000203 mixture Substances 0.000 claims abstract description 104
• 230000004069 differentiation Effects 0.000 claims description 191
• 239000003112 inhibitor Substances 0.000 claims description 178
• 210000001900 endoderm Anatomy 0.000 claims description 135
• 150000001875 compounds Chemical class 0.000 claims description 132
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 106
• 238000004113 cell culture Methods 0.000 claims description 104
• 239000003795 chemical substances by application Substances 0.000 claims description 93
• 239000003550 marker Substances 0.000 claims description 90
• 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 claims description 82
• 210000004039 endoderm cell Anatomy 0.000 claims description 81
• 230000001472 cytotoxic effect Effects 0.000 claims description 79
• 231100000433 cytotoxic Toxicity 0.000 claims description 78
• 210000000130 stem cell Anatomy 0.000 claims description 75
• 102100041030 Pancreas/duodenum homeobox protein 1 Human genes 0.000 claims description 73
• 101710183548 Pyridoxal 5'-phosphate synthase subunit PdxS Proteins 0.000 claims description 72
• 210000002438 upper gastrointestinal tract Anatomy 0.000 claims description 59
• 230000000694 effects Effects 0.000 claims description 54
• 108090001061 Insulin Proteins 0.000 claims description 53
• 102000004877 Insulin Human genes 0.000 claims description 53
• 229940125396 insulin Drugs 0.000 claims description 53
• QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 52
• -1 PROX Proteins 0.000 claims description 50
• 239000000725 suspension Substances 0.000 claims description 50
• 230000035755 proliferation Effects 0.000 claims description 48
• 239000003102 growth factor Substances 0.000 claims description 46
• 210000002966 serum Anatomy 0.000 claims description 45
• WEEFNMFMNMASJY-UHFFFAOYSA-M 1,2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium;chloride Chemical compound [Cl-].C1=C2OCOC2=CC2=CC=C3C4=CC=C(OC)C(OC)=C4C=[N+](C)C3=C21 WEEFNMFMNMASJY-UHFFFAOYSA-M 0.000 claims description 34
• 230000002124 endocrine Effects 0.000 claims description 30
• QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 27
• ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 26
• 229940074360 caffeic acid Drugs 0.000 claims description 26
• 235000004883 caffeic acid Nutrition 0.000 claims description 26
• 239000002243 precursor Substances 0.000 claims description 26
• 230000035899 viability Effects 0.000 claims description 26
• SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 claims description 24
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 24
• 229940124639 Selective inhibitor Drugs 0.000 claims description 24
• 239000006143 cell culture medium Substances 0.000 claims description 24
• AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 claims description 22
• 238000003556 assay Methods 0.000 claims description 22
• 229960002418 ivermectin Drugs 0.000 claims description 22
• 239000012190 activator Substances 0.000 claims description 21
• 238000004114 suspension culture Methods 0.000 claims description 21
• 238000004115 adherent culture Methods 0.000 claims description 20
• 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 19
• 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 19
• 101000578254 Homo sapiens Homeobox protein Nkx-6.1 Proteins 0.000 claims description 18
• 108700014808 Homeobox Protein Nkx-2.2 Proteins 0.000 claims description 17
• 102100028096 Homeobox protein Nkx-6.2 Human genes 0.000 claims description 17
• 101000578258 Homo sapiens Homeobox protein Nkx-6.2 Proteins 0.000 claims description 17
• 230000011664 signaling Effects 0.000 claims description 17
• 101100518002 Danio rerio nkx2.2a gene Proteins 0.000 claims description 16
• 102100027886 Homeobox protein Nkx-2.2 Human genes 0.000 claims description 16
• 101100460496 Homo sapiens NKX2-2 gene Proteins 0.000 claims description 16
• 101000603702 Homo sapiens Neurogenin-3 Proteins 0.000 claims description 16
• 102100038553 Neurogenin-3 Human genes 0.000 claims description 16
• 238000012258 culturing Methods 0.000 claims description 16
• 101000738523 Homo sapiens Pancreas transcription factor 1 subunit alpha Proteins 0.000 claims description 15
• 101000652324 Homo sapiens Transcription factor SOX-17 Proteins 0.000 claims description 15
• 102100037878 Pancreas transcription factor 1 subunit alpha Human genes 0.000 claims description 15
• 102000013275 Somatomedins Human genes 0.000 claims description 15
• 102100030243 Transcription factor SOX-17 Human genes 0.000 claims description 15
• SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical class OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 14
• 230000037361 pathway Effects 0.000 claims description 14
• 102100029284 Hepatocyte nuclear factor 3-beta Human genes 0.000 claims description 13
• 101001062347 Homo sapiens Hepatocyte nuclear factor 3-beta Proteins 0.000 claims description 13
• 239000002254 cytotoxic agent Substances 0.000 claims description 13
• 229940127089 cytotoxic agent Drugs 0.000 claims description 13
• 231100000599 cytotoxic agent Toxicity 0.000 claims description 13
• 238000010186 staining Methods 0.000 claims description 13
• 101000923091 Danio rerio Aristaless-related homeobox protein Proteins 0.000 claims description 12
• 102100031470 Homeobox protein ARX Human genes 0.000 claims description 12
• 101000923090 Homo sapiens Homeobox protein ARX Proteins 0.000 claims description 12
• 101100239628 Danio rerio myca gene Proteins 0.000 claims description 11
• 102100022054 Hepatocyte nuclear factor 4-alpha Human genes 0.000 claims description 11
• 102100029087 Hepatocyte nuclear factor 6 Human genes 0.000 claims description 11
• 101001045740 Homo sapiens Hepatocyte nuclear factor 4-alpha Proteins 0.000 claims description 11
• 101000988619 Homo sapiens Hepatocyte nuclear factor 6 Proteins 0.000 claims description 11
• 101000613495 Homo sapiens Paired box protein Pax-4 Proteins 0.000 claims description 11
• 102100040909 Paired box protein Pax-4 Human genes 0.000 claims description 11
• 102100023635 Alpha-fetoprotein Human genes 0.000 claims description 10
• 101800001586 Ghrelin Proteins 0.000 claims description 10
• 102000012004 Ghrelin Human genes 0.000 claims description 10
• 241000288906 Primates Species 0.000 claims description 10
• 230000003213 activating effect Effects 0.000 claims description 10
• 102000005962 receptors Human genes 0.000 claims description 10
• 108020003175 receptors Proteins 0.000 claims description 10
• 239000011435 rock Substances 0.000 claims description 10
• 102100024208 Homeobox protein MIXL1 Human genes 0.000 claims description 9
• 102100038146 Homeobox protein goosecoid Human genes 0.000 claims description 9
• 101001052462 Homo sapiens Homeobox protein MIXL1 Proteins 0.000 claims description 9
• 101001032602 Homo sapiens Homeobox protein goosecoid Proteins 0.000 claims description 9
• 108010032788 PAX6 Transcription Factor Proteins 0.000 claims description 9
• 102100037506 Paired box protein Pax-6 Human genes 0.000 claims description 9
• 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims description 8
• 102400001244 Cerebellin Human genes 0.000 claims description 8
• 101800001299 Cerebellin Proteins 0.000 claims description 8
• 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims description 8
• 101001069749 Homo sapiens Prospero homeobox protein 1 Proteins 0.000 claims description 8
• 102100033880 Prospero homeobox protein 1 Human genes 0.000 claims description 8
• 102000013814 Wnt Human genes 0.000 claims description 8
• 108050003627 Wnt Proteins 0.000 claims description 8
• 102100029283 Hepatocyte nuclear factor 3-alpha Human genes 0.000 claims description 7
• 101001062353 Homo sapiens Hepatocyte nuclear factor 3-alpha Proteins 0.000 claims description 7
• 101000976653 Homo sapiens Zinc finger protein ZIC 1 Proteins 0.000 claims description 7
• 102100023497 Zinc finger protein ZIC 1 Human genes 0.000 claims description 7
• LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 claims description 6
• 102100030751 Eomesodermin homolog Human genes 0.000 claims description 6
• 229940125373 Gamma-Secretase Inhibitor Drugs 0.000 claims description 6
• 101001064167 Homo sapiens Eomesodermin homolog Proteins 0.000 claims description 6
• 101000652332 Homo sapiens Transcription factor SOX-1 Proteins 0.000 claims description 6
• 102100030248 Transcription factor SOX-1 Human genes 0.000 claims description 6
• 239000003540 gamma secretase inhibitor Substances 0.000 claims description 6
• 102100022716 Atypical chemokine receptor 3 Human genes 0.000 claims description 5
• 102100038520 Calcitonin receptor Human genes 0.000 claims description 5
• 108010038447 Chromogranin A Proteins 0.000 claims description 5
• 102000010792 Chromogranin A Human genes 0.000 claims description 5
• 102100032756 Cysteine-rich protein 1 Human genes 0.000 claims description 5
• 102100035308 Fibroblast growth factor 17 Human genes 0.000 claims description 5
• 102100027570 Forkhead box protein Q1 Human genes 0.000 claims description 5
• 101000678890 Homo sapiens Atypical chemokine receptor 3 Proteins 0.000 claims description 5
• 101000945426 Homo sapiens CB1 cannabinoid receptor-interacting protein 1 Proteins 0.000 claims description 5
• 101000741435 Homo sapiens Calcitonin receptor Proteins 0.000 claims description 5
• 101000942084 Homo sapiens Cysteine-rich protein 1 Proteins 0.000 claims description 5
• 101000878124 Homo sapiens Fibroblast growth factor 17 Proteins 0.000 claims description 5
• 101000861406 Homo sapiens Forkhead box protein Q1 Proteins 0.000 claims description 5
• 101000613490 Homo sapiens Paired box protein Pax-3 Proteins 0.000 claims description 5
• 101000819074 Homo sapiens Transcription factor GATA-4 Proteins 0.000 claims description 5
• 102100040891 Paired box protein Pax-3 Human genes 0.000 claims description 5
• 102100021380 Transcription factor GATA-4 Human genes 0.000 claims description 5
• 102100024270 Transcription factor SOX-2 Human genes 0.000 claims description 5
• 230000009467 reduction Effects 0.000 claims description 5
• 238000002965 ELISA Methods 0.000 claims description 4
• 101000976075 Homo sapiens Insulin Proteins 0.000 claims description 4
• 101000979321 Homo sapiens Neurofilament medium polypeptide Proteins 0.000 claims description 4
• 101000642523 Homo sapiens Transcription factor SOX-7 Proteins 0.000 claims description 4
• 102100023055 Neurofilament medium polypeptide Human genes 0.000 claims description 4
• 102100036730 Transcription factor SOX-7 Human genes 0.000 claims description 4
• 238000001262 western blot Methods 0.000 claims description 4
• 101000971533 Homo sapiens Killer cell lectin-like receptor subfamily G member 1 Proteins 0.000 claims description 3
• 101000979205 Homo sapiens Transcription factor MafA Proteins 0.000 claims description 3
• 101000642517 Homo sapiens Transcription factor SOX-6 Proteins 0.000 claims description 3
• 102100021457 Killer cell lectin-like receptor subfamily G member 1 Human genes 0.000 claims description 3
• 238000000636 Northern blotting Methods 0.000 claims description 3
• 102100036694 Transcription factor SOX-6 Human genes 0.000 claims description 3
• 239000002253 acid Substances 0.000 claims description 3
• 238000010166 immunofluorescence Methods 0.000 claims description 3
• OGQSCIYDJSNCMY-UHFFFAOYSA-H iron(3+);methyl-dioxido-oxo-$l^{5}-arsane Chemical compound [Fe+3].[Fe+3].C[As]([O-])([O-])=O.C[As]([O-])([O-])=O.C[As]([O-])([O-])=O OGQSCIYDJSNCMY-UHFFFAOYSA-H 0.000 claims description 3
• 150000004492 retinoid derivatives Chemical class 0.000 claims description 3
• 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 claims description 2
• 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 claims description 2
• 229940121827 Hedgehog pathway inhibitor Drugs 0.000 claims description 2
• 102100022057 Hepatocyte nuclear factor 1-alpha Human genes 0.000 claims 10
• 101001045751 Homo sapiens Hepatocyte nuclear factor 1-alpha Proteins 0.000 claims 10
• 101000711846 Homo sapiens Transcription factor SOX-9 Proteins 0.000 claims 5
• 102100034204 Transcription factor SOX-9 Human genes 0.000 claims 5
• 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 claims 4
• 101710123134 Ice-binding protein Proteins 0.000 claims 2
• 101710082837 Ice-structuring protein Proteins 0.000 claims 2
• 102100023915 Insulin Human genes 0.000 claims 2
• 101710107540 Type-2 ice-structuring protein Proteins 0.000 claims 2
• 241000289669 Erinaceus europaeus Species 0.000 claims 1
• 238000001190 Q-PCR Methods 0.000 claims 1
• 230000004663 cell proliferation Effects 0.000 abstract description 6
• 230000014509 gene expression Effects 0.000 description 125
• 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 76
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 72
• 239000002609 medium Substances 0.000 description 58
• 210000004263 induced pluripotent stem cell Anatomy 0.000 description 57
• 210000002950 fibroblast Anatomy 0.000 description 53
• 108090000623 proteins and genes Proteins 0.000 description 52
• 230000012010 growth Effects 0.000 description 37
• 238000003753 real-time PCR Methods 0.000 description 35
• 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 32
• 238000004519 manufacturing process Methods 0.000 description 31
• 241001465754 Metazoa Species 0.000 description 27
• 201000010099 disease Diseases 0.000 description 27
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 27
• 102000004196 processed proteins & peptides Human genes 0.000 description 24
• 108090000765 processed proteins & peptides Proteins 0.000 description 24
• 101001139134 Homo sapiens Krueppel-like factor 4 Proteins 0.000 description 23
• 102100020677 Krueppel-like factor 4 Human genes 0.000 description 23
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 22
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 22
• 101710150448 Transcriptional regulator Myc Proteins 0.000 description 22
• 229920001184 polypeptide Polymers 0.000 description 22
• 230000008569 process Effects 0.000 description 22
• TUCIOBMMDDOEMM-RIYZIHGNSA-N tyrphostin B42 Chemical compound C1=C(O)C(O)=CC=C1\C=C(/C#N)C(=O)NCC1=CC=CC=C1 TUCIOBMMDDOEMM-RIYZIHGNSA-N 0.000 description 22
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 21
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 21
• 230000001965 increasing effect Effects 0.000 description 20
• 102000004169 proteins and genes Human genes 0.000 description 20
• 238000012216 screening Methods 0.000 description 20
• 230000004083 survival effect Effects 0.000 description 20
• LOGJQOUIVKBFGH-YBEGLDIGSA-N (3z)-n,n-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1h-indol-2-ylmethylidene)-2,3-dihydro-1h-indole-5-sulfonamide Chemical compound C1CCCC(N2)=C1C=C2\C=C1/C(=O)NC2=CC=C(S(=O)(=O)N(C)C)C=C21 LOGJQOUIVKBFGH-YBEGLDIGSA-N 0.000 description 19
• 235000018102 proteins Nutrition 0.000 description 19
• 210000001082 somatic cell Anatomy 0.000 description 17
• 210000003890 endocrine cell Anatomy 0.000 description 16
• 208000037149 Facioscapulohumeral dystrophy Diseases 0.000 description 15
• 210000002242 embryoid body Anatomy 0.000 description 15
• 208000008570 facioscapulohumeral muscular dystrophy Diseases 0.000 description 15
• 239000012634 fragment Substances 0.000 description 14
• 230000006698 induction Effects 0.000 description 14
• 239000006285 cell suspension Substances 0.000 description 13
• 230000007423 decrease Effects 0.000 description 13
• HCJOLYFWJWJPTJ-UHFFFAOYSA-N dephostatin Chemical group O=NN(C)C1=CC(O)=CC=C1O HCJOLYFWJWJPTJ-UHFFFAOYSA-N 0.000 description 13
• 239000001963 growth medium Substances 0.000 description 13
• 239000000243 solution Substances 0.000 description 13
• 201000003883 Cystic fibrosis Diseases 0.000 description 12
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 12
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 12
• 238000005516 engineering process Methods 0.000 description 12
• 210000001519 tissue Anatomy 0.000 description 12
• 238000011282 treatment Methods 0.000 description 12
• 230000015572 biosynthetic process Effects 0.000 description 11
• 230000003013 cytotoxicity Effects 0.000 description 11
• 231100000135 cytotoxicity Toxicity 0.000 description 11
• 238000000338 in vitro Methods 0.000 description 11
• 239000000523 sample Substances 0.000 description 11
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 10
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 10
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 10
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 10
• 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 10
• 206010043276 Teratoma Diseases 0.000 description 10
• 238000004458 analytical method Methods 0.000 description 10
• 229940126864 fibroblast growth factor Drugs 0.000 description 10
• 239000010410 layer Substances 0.000 description 10
• 238000007747 plating Methods 0.000 description 10
• 230000008672 reprogramming Effects 0.000 description 10
• 238000011160 research Methods 0.000 description 10
• 101710090028 Inositol-3-phosphate synthase 1 Proteins 0.000 description 9
• 102100036881 Inositol-3-phosphate synthase 1 Human genes 0.000 description 9
• 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 9
• 210000001776 amniocyte Anatomy 0.000 description 9
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 9
• 238000013459 approach Methods 0.000 description 9
• 239000012530 fluid Substances 0.000 description 9
• 230000006870 function Effects 0.000 description 9
• 229940088597 hormone Drugs 0.000 description 9
• 239000005556 hormone Substances 0.000 description 9
• 238000001727 in vivo Methods 0.000 description 9
• 210000005155 neural progenitor cell Anatomy 0.000 description 9
• 229930002330 retinoic acid Natural products 0.000 description 9
• 108010041788 rho-Associated Kinases Proteins 0.000 description 9
• 102000000568 rho-Associated Kinases Human genes 0.000 description 9
• 150000003839 salts Chemical class 0.000 description 9
• 239000000126 substance Substances 0.000 description 9
• 229960001727 tretinoin Drugs 0.000 description 9
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
• 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 8
• 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 8
• 201000010374 Down Syndrome Diseases 0.000 description 8
• 102100034239 Emerin Human genes 0.000 description 8
• 201000009344 Emery-Dreifuss muscular dystrophy Diseases 0.000 description 8
• 102000051325 Glucagon Human genes 0.000 description 8
• 108060003199 Glucagon Proteins 0.000 description 8
• 241000713666 Lentivirus Species 0.000 description 8
• 108010071390 Serum Albumin Proteins 0.000 description 8
• 102000007562 Serum Albumin Human genes 0.000 description 8
• 108010023082 activin A Proteins 0.000 description 8
• 230000002776 aggregation Effects 0.000 description 8
• 238000004220 aggregation Methods 0.000 description 8
• 108010026331 alpha-Fetoproteins Proteins 0.000 description 8
• 239000005557 antagonist Substances 0.000 description 8
• 230000006907 apoptotic process Effects 0.000 description 8
• 229940112869 bone morphogenetic protein Drugs 0.000 description 8
• 230000003247 decreasing effect Effects 0.000 description 8
• 238000011161 development Methods 0.000 description 8
• 230000018109 developmental process Effects 0.000 description 8
• 238000010494 dissociation reaction Methods 0.000 description 8
• 230000005593 dissociations Effects 0.000 description 8
• 229940079593 drug Drugs 0.000 description 8
• 239000003814 drug Substances 0.000 description 8
• 210000001671 embryonic stem cell Anatomy 0.000 description 8
• 238000005538 encapsulation Methods 0.000 description 8
• 230000002255 enzymatic effect Effects 0.000 description 8
• MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 8
• 229960004666 glucagon Drugs 0.000 description 8
• 239000003446 ligand Substances 0.000 description 8
• 101150111214 lin-28 gene Proteins 0.000 description 8
• 238000012544 monitoring process Methods 0.000 description 8
• 230000002829 reductive effect Effects 0.000 description 8
• 150000003384 small molecules Chemical class 0.000 description 8
• 239000000758 substrate Substances 0.000 description 8
• 239000013589 supplement Substances 0.000 description 8
• 244000060234 Gmelina philippensis Species 0.000 description 7
• 102000052651 Pancreatic hormone Human genes 0.000 description 7
• 239000000556 agonist Substances 0.000 description 7
• 230000003833 cell viability Effects 0.000 description 7
• 230000002500 effect on skin Effects 0.000 description 7
• 210000002304 esc Anatomy 0.000 description 7
• 239000012091 fetal bovine serum Substances 0.000 description 7
• 238000000684 flow cytometry Methods 0.000 description 7
• 210000003953 foreskin Anatomy 0.000 description 7
• 210000004153 islets of langerhan Anatomy 0.000 description 7
• 210000002894 multi-fate stem cell Anatomy 0.000 description 7
• 102000045246 noggin Human genes 0.000 description 7
• 108700007229 noggin Proteins 0.000 description 7
• 235000015097 nutrients Nutrition 0.000 description 7
• 239000004025 pancreas hormone Substances 0.000 description 7
• 230000009996 pancreatic endocrine effect Effects 0.000 description 7
• 229940032957 pancreatic hormone Drugs 0.000 description 7
• FKRBAXZAJBBIAJ-UHFFFAOYSA-N 5-cyano-7-nitro-3-oxido-1,3-benzothiazol-3-ium-2-carboxamide Chemical group C1=C(C#N)C=C2[N+]([O-])=C(C(=O)N)SC2=C1[N+]([O-])=O FKRBAXZAJBBIAJ-UHFFFAOYSA-N 0.000 description 6
• 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 6
• 108091008794 FGF receptors Proteins 0.000 description 6
• 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 description 6
• 102100028412 Fibroblast growth factor 10 Human genes 0.000 description 6
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 6
• 208000023105 Huntington disease Diseases 0.000 description 6
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 6
• 101150085710 OCT4 gene Proteins 0.000 description 6
• 102000019197 Superoxide Dismutase Human genes 0.000 description 6
• 108010012715 Superoxide dismutase Proteins 0.000 description 6
• 210000000677 aggregate cell Anatomy 0.000 description 6
• 150000001413 amino acids Chemical group 0.000 description 6
• 230000024245 cell differentiation Effects 0.000 description 6
• 239000000356 contaminant Substances 0.000 description 6
• 238000002474 experimental method Methods 0.000 description 6
• 210000002744 extracellular matrix Anatomy 0.000 description 6
• 229960002743 glutamine Drugs 0.000 description 6
• 230000033001 locomotion Effects 0.000 description 6
• 238000005259 measurement Methods 0.000 description 6
• 102000039446 nucleic acids Human genes 0.000 description 6
• 108020004707 nucleic acids Proteins 0.000 description 6
• 150000007523 nucleic acids Chemical class 0.000 description 6
• 239000002773 nucleotide Substances 0.000 description 6
• 125000003729 nucleotide group Chemical group 0.000 description 6
• 230000010412 perfusion Effects 0.000 description 6
• 239000000047 product Substances 0.000 description 6
• 238000013341 scale-up Methods 0.000 description 6
• QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 6
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
• 108010083123 CDX2 Transcription Factor Proteins 0.000 description 5
• 102000006277 CDX2 Transcription Factor Human genes 0.000 description 5
• 101800001318 Capsid protein VP4 Proteins 0.000 description 5
• 102000004190 Enzymes Human genes 0.000 description 5
• 108090000790 Enzymes Proteins 0.000 description 5
• 101710194452 Growth/differentiation factor 11 Proteins 0.000 description 5
• 102100040898 Growth/differentiation factor 11 Human genes 0.000 description 5
• 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 5
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
• 108010056852 Myostatin Proteins 0.000 description 5
• 206010028980 Neoplasm Diseases 0.000 description 5
• 239000013614 RNA sample Substances 0.000 description 5
• 102100027609 Rho-related GTP-binding protein RhoD Human genes 0.000 description 5
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 5
• 108010009583 Transforming Growth Factors Proteins 0.000 description 5
• 102000009618 Transforming Growth Factors Human genes 0.000 description 5
• 108090000631 Trypsin Proteins 0.000 description 5
• 102000004142 Trypsin Human genes 0.000 description 5
• SCJNCDSAIRBRIA-DOFZRALJSA-N arachidonyl-2'-chloroethylamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl SCJNCDSAIRBRIA-DOFZRALJSA-N 0.000 description 5
• 230000027455 binding Effects 0.000 description 5
• 230000000903 blocking effect Effects 0.000 description 5
• YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 5
• 238000006243 chemical reaction Methods 0.000 description 5
• 230000002354 daily effect Effects 0.000 description 5
• 210000002257 embryonic structure Anatomy 0.000 description 5
• 229940088598 enzyme Drugs 0.000 description 5
• 210000000981 epithelium Anatomy 0.000 description 5
• 230000001747 exhibiting effect Effects 0.000 description 5
• 210000001654 germ layer Anatomy 0.000 description 5
• 238000003364 immunohistochemistry Methods 0.000 description 5
• 239000012535 impurity Substances 0.000 description 5
• 210000002510 keratinocyte Anatomy 0.000 description 5
• 229940043355 kinase inhibitor Drugs 0.000 description 5
• 230000007246 mechanism Effects 0.000 description 5
• 230000004048 modification Effects 0.000 description 5
• 238000012986 modification Methods 0.000 description 5
• 239000002858 neurotransmitter agent Substances 0.000 description 5
• 239000003757 phosphotransferase inhibitor Substances 0.000 description 5
• 230000002062 proliferating effect Effects 0.000 description 5
• 230000001737 promoting effect Effects 0.000 description 5
• 239000003590 rho kinase inhibitor Substances 0.000 description 5
• 239000007858 starting material Substances 0.000 description 5
• 239000011573 trace mineral Substances 0.000 description 5
• 235000013619 trace mineral Nutrition 0.000 description 5
• 239000012588 trypsin Substances 0.000 description 5
• YGEIMSMISRCBFF-UHFFFAOYSA-M 1-[bis(4-chlorophenyl)methyl]-3-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazol-3-ium;chloride Chemical compound [Cl-].C1=CC(Cl)=CC=C1C([N+]1=CN(CC(OCC=2C(=CC(Cl)=CC=2)Cl)C=2C(=CC(Cl)=CC=2)Cl)C=C1)C1=CC=C(Cl)C=C1 YGEIMSMISRCBFF-UHFFFAOYSA-M 0.000 description 4
• 201000006935 Becker muscular dystrophy Diseases 0.000 description 4
• 108091006146 Channels Proteins 0.000 description 4
• 108010069091 Dystrophin Proteins 0.000 description 4
• 108090001047 Fibroblast growth factor 10 Proteins 0.000 description 4
• 108050002062 Fibroblast growth factor 22 Proteins 0.000 description 4
• 102100024804 Fibroblast growth factor 22 Human genes 0.000 description 4
• 108010054147 Hemoglobins Proteins 0.000 description 4
• 102000001554 Hemoglobins Human genes 0.000 description 4
• 101001060261 Homo sapiens Fibroblast growth factor 7 Proteins 0.000 description 4
• 108010001127 Insulin Receptor Proteins 0.000 description 4
• 102100036721 Insulin receptor Human genes 0.000 description 4
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 4
• 206010068871 Myotonic dystrophy Diseases 0.000 description 4
• 102100022437 Myotonin-protein kinase Human genes 0.000 description 4
• MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
• 108700020479 Pancreatic hormone Proteins 0.000 description 4
• 101800001268 Pancreatic hormone Proteins 0.000 description 4
• 102100033237 Pro-epidermal growth factor Human genes 0.000 description 4
• 102000003923 Protein Kinase C Human genes 0.000 description 4
• 108090000315 Protein Kinase C Proteins 0.000 description 4
• 102000004338 Transferrin Human genes 0.000 description 4
• 108090000901 Transferrin Proteins 0.000 description 4
• 208000026911 Tuberous sclerosis complex Diseases 0.000 description 4
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 4
• 230000009471 action Effects 0.000 description 4
• 108010023079 activin B Proteins 0.000 description 4
• 230000001464 adherent effect Effects 0.000 description 4
• 229940024606 amino acid Drugs 0.000 description 4
• 235000001014 amino acid Nutrition 0.000 description 4
• FOIVPCKZDPCJJY-JQIJEIRASA-N arotinoid acid Chemical compound C=1C=C(C(CCC2(C)C)(C)C)C2=CC=1C(/C)=C/C1=CC=C(C(O)=O)C=C1 FOIVPCKZDPCJJY-JQIJEIRASA-N 0.000 description 4
• 208000036556 autosomal recessive T cell-negative B cell-negative NK cell-negative due to adenosine deaminase deficiency severe combined immunodeficiency Diseases 0.000 description 4
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
• 230000004071 biological effect Effects 0.000 description 4
• 238000002659 cell therapy Methods 0.000 description 4
• 230000017455 cell-cell adhesion Effects 0.000 description 4
• 238000012512 characterization method Methods 0.000 description 4
• 239000002299 complementary DNA Substances 0.000 description 4
• 239000003636 conditioned culture medium Substances 0.000 description 4
• 210000004292 cytoskeleton Anatomy 0.000 description 4
• 239000000824 cytostatic agent Substances 0.000 description 4
• 230000001085 cytostatic effect Effects 0.000 description 4
• 238000001514 detection method Methods 0.000 description 4
• 210000002308 embryonic cell Anatomy 0.000 description 4
• HCZKYJDFEPMADG-UHFFFAOYSA-N erythro-nordihydroguaiaretic acid Natural products C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 4
• 210000000646 extraembryonic cell Anatomy 0.000 description 4
• 210000004602 germ cell Anatomy 0.000 description 4
• 210000005260 human cell Anatomy 0.000 description 4
• 230000005764 inhibitory process Effects 0.000 description 4
• HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 4
• TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 4
• 201000006938 muscular dystrophy Diseases 0.000 description 4
• 230000001537 neural effect Effects 0.000 description 4
• SWUARLUWKZWEBQ-VQHVLOKHSA-N phenethyl caffeate Chemical compound C1=C(O)C(O)=CC=C1\C=C\C(=O)OCCC1=CC=CC=C1 SWUARLUWKZWEBQ-VQHVLOKHSA-N 0.000 description 4
• 230000026731 phosphorylation Effects 0.000 description 4
• 238000006366 phosphorylation reaction Methods 0.000 description 4
• 208000002320 spinal muscular atrophy Diseases 0.000 description 4
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
• 210000002262 tip cell Anatomy 0.000 description 4
• 239000012581 transferrin Substances 0.000 description 4
• 230000017105 transposition Effects 0.000 description 4
• 208000009999 tuberous sclerosis Diseases 0.000 description 4
• 229940088594 vitamin Drugs 0.000 description 4
• 229930003231 vitamin Natural products 0.000 description 4
• 235000013343 vitamin Nutrition 0.000 description 4
• 239000011782 vitamin Substances 0.000 description 4
• HKHOVJYOELRGMV-XYOKQWHBSA-N (e)-2-cyano-3-(3,4-dihydroxyphenyl)-n-phenylprop-2-enamide Chemical compound C1=C(O)C(O)=CC=C1\C=C(/C#N)C(=O)NC1=CC=CC=C1 HKHOVJYOELRGMV-XYOKQWHBSA-N 0.000 description 3
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 3
• IYOZTVGMEWJPKR-VOMCLLRMSA-N 4-[(1R)-1-aminoethyl]-N-pyridin-4-yl-1-cyclohexanecarboxamide Chemical compound C1CC([C@H](N)C)CCC1C(=O)NC1=CC=NC=C1 IYOZTVGMEWJPKR-VOMCLLRMSA-N 0.000 description 3
• HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 3
• 108700028369 Alleles Proteins 0.000 description 3
• LLEJIEBFSOEYIV-UHFFFAOYSA-N Chelerythrine Natural products C1=C2OCOC2=CC2=CC=C3C4=CC=C(OC)C(OC)=C4C=[N+](C)C3=C21 LLEJIEBFSOEYIV-UHFFFAOYSA-N 0.000 description 3
• RATMHCJTVBHJSU-UHFFFAOYSA-N Dihydrochelerythrine Natural products C1=C2OCOC2=CC2=C(N(C)C(O)C=3C4=CC=C(C=3OC)OC)C4=CC=C21 RATMHCJTVBHJSU-UHFFFAOYSA-N 0.000 description 3
• 108700039887 Essential Genes Proteins 0.000 description 3
• 102100037362 Fibronectin Human genes 0.000 description 3
• 108010067306 Fibronectins Proteins 0.000 description 3
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
• 101150068639 Hnf4a gene Proteins 0.000 description 3
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 3
• 229930182816 L-glutamine Natural products 0.000 description 3
• 102000035195 Peptidases Human genes 0.000 description 3
• 108091005804 Peptidases Proteins 0.000 description 3
• 108091000080 Phosphotransferase Proteins 0.000 description 3
• 239000004365 Protease Substances 0.000 description 3
• 108091005682 Receptor kinases Proteins 0.000 description 3
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 3
• BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
• 102000040945 Transcription factor Human genes 0.000 description 3
• 108091023040 Transcription factor Proteins 0.000 description 3
• 102000004887 Transforming Growth Factor beta Human genes 0.000 description 3
• 108090001012 Transforming Growth Factor beta Proteins 0.000 description 3
• 206010044688 Trisomy 21 Diseases 0.000 description 3
• 101150045640 VWF gene Proteins 0.000 description 3
• 210000004504 adult stem cell Anatomy 0.000 description 3
• 238000013019 agitation Methods 0.000 description 3
• 230000003321 amplification Effects 0.000 description 3
• 239000000427 antigen Substances 0.000 description 3
• 108091007433 antigens Proteins 0.000 description 3
• 102000036639 antigens Human genes 0.000 description 3
• 235000010323 ascorbic acid Nutrition 0.000 description 3
• 229960005070 ascorbic acid Drugs 0.000 description 3
• 239000011668 ascorbic acid Substances 0.000 description 3
• 208000005980 beta thalassemia Diseases 0.000 description 3
• 230000033228 biological regulation Effects 0.000 description 3
• WWVKQTNONPWVEL-UHFFFAOYSA-N caffeic acid phenethyl ester Natural products C1=C(O)C(O)=CC=C1C=CC(=O)OCC1=CC=CC=C1 WWVKQTNONPWVEL-UHFFFAOYSA-N 0.000 description 3
• 201000011510 cancer Diseases 0.000 description 3
• 230000022131 cell cycle Effects 0.000 description 3
• 239000002771 cell marker Substances 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• IDDDVXIUIXWAGJ-LJDSMOQUSA-N chembl1605605 Chemical compound Cl.Cl.C1C[C@@H]([C@H](N)C)CC[C@@H]1C(=O)NC1=CC=NC=C1 IDDDVXIUIXWAGJ-LJDSMOQUSA-N 0.000 description 3
• 125000003636 chemical group Chemical group 0.000 description 3
• 229960002424 collagenase Drugs 0.000 description 3
• 239000013078 crystal Substances 0.000 description 3
• 210000004748 cultured cell Anatomy 0.000 description 3
• 238000010790 dilution Methods 0.000 description 3
• 239000012895 dilution Substances 0.000 description 3
• 239000012894 fetal calf serum Substances 0.000 description 3
• 230000001605 fetal effect Effects 0.000 description 3
• 238000009472 formulation Methods 0.000 description 3
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
• 238000003365 immunocytochemistry Methods 0.000 description 3
• 230000001976 improved effect Effects 0.000 description 3
• 229910052500 inorganic mineral Inorganic materials 0.000 description 3
• 230000003834 intracellular effect Effects 0.000 description 3
• 210000001161 mammalian embryo Anatomy 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• 210000003716 mesoderm Anatomy 0.000 description 3
• 235000010755 mineral Nutrition 0.000 description 3
• 239000011707 mineral Substances 0.000 description 3
• 210000002161 motor neuron Anatomy 0.000 description 3
• 206010051747 multiple endocrine neoplasia Diseases 0.000 description 3
• 201000009340 myotonic dystrophy type 1 Diseases 0.000 description 3
• WDHRPWOAMDJICD-FOAQWNCLSA-N n-[2-[(3'r,3'as,6's,6as,6bs,7'ar,9r,11as,11br)-3',6',10,11b-tetramethyl-3-oxospiro[1,2,4,6,6a,6b,7,8,11,11a-decahydrobenzo[a]fluorene-9,2'-3,3a,5,6,7,7a-hexahydrofuro[3,2-b]pyridine]-4'-yl]ethyl]-6-(3-phenylpropanoylamino)hexanamide Chemical group C([C@@H](C)C[C@@H]1[C@@H]2[C@H]([C@]3(C(=C4C[C@@H]5[C@@]6(C)CCC(=O)CC6=CC[C@H]5[C@@H]4CC3)C)O1)C)N2CCNC(=O)CCCCCNC(=O)CCC1=CC=CC=C1 WDHRPWOAMDJICD-FOAQWNCLSA-N 0.000 description 3
• 230000017066 negative regulation of growth Effects 0.000 description 3
• 210000002569 neuron Anatomy 0.000 description 3
• 238000003199 nucleic acid amplification method Methods 0.000 description 3
• 150000002894 organic compounds Chemical class 0.000 description 3
• 210000000496 pancreas Anatomy 0.000 description 3
• 210000003577 pancreatic endocrine progenitor Anatomy 0.000 description 3
• 239000000546 pharmaceutical excipient Substances 0.000 description 3
• SWUARLUWKZWEBQ-UHFFFAOYSA-N phenylethyl ester of caffeic acid Natural products C1=C(O)C(O)=CC=C1C=CC(=O)OCCC1=CC=CC=C1 SWUARLUWKZWEBQ-UHFFFAOYSA-N 0.000 description 3
• 102000020233 phosphotransferase Human genes 0.000 description 3
• 230000001172 regenerating effect Effects 0.000 description 3
• 230000001105 regulatory effect Effects 0.000 description 3
• 230000004044 response Effects 0.000 description 3
• 239000012465 retentate Substances 0.000 description 3
• 238000007790 scraping Methods 0.000 description 3
• 230000003248 secreting effect Effects 0.000 description 3
• 229910052711 selenium Inorganic materials 0.000 description 3
• 239000011669 selenium Substances 0.000 description 3
• 229940076279 serotonin Drugs 0.000 description 3
• SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 238000006467 substitution reaction Methods 0.000 description 3
• 238000012360 testing method Methods 0.000 description 3
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 3
• 208000032471 type 1 spinal muscular atrophy Diseases 0.000 description 3
• 229960004441 tyrosine Drugs 0.000 description 3
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
• 102100036537 von Willebrand factor Human genes 0.000 description 3
• 239000002699 waste material Substances 0.000 description 3
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
• GSQOBTOAOGXIFL-LFIBNONCSA-N (e)-2-cyano-3-(3,4-dihydroxyphenyl)-n-(3-phenylpropyl)prop-2-enamide Chemical compound C1=C(O)C(O)=CC=C1\C=C(/C#N)C(=O)NCCCC1=CC=CC=C1 GSQOBTOAOGXIFL-LFIBNONCSA-N 0.000 description 2
• GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 2
• KBPZBOSJIZEELA-UHFFFAOYSA-N 1-[2-[4-methoxy-3-[3-(4-methoxyphenyl)propoxy]phenyl]ethyl]imidazole;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1CCCOC1=CC(CCN2C=NC=C2)=CC=C1OC KBPZBOSJIZEELA-UHFFFAOYSA-N 0.000 description 2
• VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
• QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 2
• CQOQDQWUFQDJMK-SSTWWWIQSA-N 2-methoxy-17beta-estradiol Chemical compound C([C@@H]12)C[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]1CCC1=C2C=C(OC)C(O)=C1 CQOQDQWUFQDJMK-SSTWWWIQSA-N 0.000 description 2
• TWBRXRGFFUATNI-UHFFFAOYSA-M 3-ethyl-2-[3-(1,3,3-trimethylindol-2-ylidene)prop-1-enyl]-1,3-benzothiazol-3-ium;iodide Chemical compound [I-].S1C2=CC=CC=C2[N+](CC)=C1\C=C\C=C\1C(C)(C)C2=CC=CC=C2N/1C TWBRXRGFFUATNI-UHFFFAOYSA-M 0.000 description 2
• UDKVBVICMUEIKS-UHFFFAOYSA-N 4-[(6-chloro-2-methoxyacridin-9-yl)azaniumyl]pentyl-diethylazanium;dichloride Chemical compound Cl.Cl.C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 UDKVBVICMUEIKS-UHFFFAOYSA-N 0.000 description 2
• DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
• 102000018918 Activin Receptors Human genes 0.000 description 2
• 108010052946 Activin Receptors Proteins 0.000 description 2
• 102100036191 Acyl-coenzyme A diphosphatase NUDT19 Human genes 0.000 description 2
• 239000005711 Benzoic acid Substances 0.000 description 2
• 101100454433 Biomphalaria glabrata BG01 gene Proteins 0.000 description 2
• 241000283690 Bos taurus Species 0.000 description 2
• HIYAVKIYRIFSCZ-CVXKHCKVSA-N Calcimycin Chemical compound CC([C@H]1OC2([C@@H](C[C@H]1C)C)O[C@H]([C@H](CC2)C)CC=1OC2=CC=C(C(=C2N=1)C(O)=O)NC)C(=O)C1=CC=CN1 HIYAVKIYRIFSCZ-CVXKHCKVSA-N 0.000 description 2
• 102000014914 Carrier Proteins Human genes 0.000 description 2
• JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 2
• 102000029816 Collagenase Human genes 0.000 description 2
• 108060005980 Collagenase Proteins 0.000 description 2
• 206010010099 Combined immunodeficiency Diseases 0.000 description 2
• 108020004414 DNA Proteins 0.000 description 2
• 101800001148 Delta-peptide Proteins 0.000 description 2
• 102000001039 Dystrophin Human genes 0.000 description 2
• OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
• 101150028412 GBA gene Proteins 0.000 description 2
• 208000028735 Gaucher disease type III Diseases 0.000 description 2
• 239000006147 Glasgow's Minimal Essential Medium Substances 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 229920002971 Heparan sulfate Polymers 0.000 description 2
• 102100022123 Hepatocyte nuclear factor 1-beta Human genes 0.000 description 2
• NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
• 101000917237 Homo sapiens Fibroblast growth factor 10 Proteins 0.000 description 2
• 101001045758 Homo sapiens Hepatocyte nuclear factor 1-beta Proteins 0.000 description 2
• 101000942967 Homo sapiens Leukemia inhibitory factor Proteins 0.000 description 2
• PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
• 108010083687 Ion Pumps Proteins 0.000 description 2
• CLEXYFLHGFJONT-DNMILWOZSA-N Jervine Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H](C(=O)C2=C3C)[C@@H]1[C@@H]2CC[C@@]13O[C@@H]2C[C@H](C)CN[C@H]2[C@H]1C CLEXYFLHGFJONT-DNMILWOZSA-N 0.000 description 2
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
• 229930182844 L-isoleucine Natural products 0.000 description 2
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
• 229930182821 L-proline Natural products 0.000 description 2
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
• 108010085895 Laminin Proteins 0.000 description 2
• QQBPLXNESPTPNU-KTKRTIGZSA-N N-oleoyldopamine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)NCCC1=CC=C(O)C(O)=C1 QQBPLXNESPTPNU-KTKRTIGZSA-N 0.000 description 2
• 108010057466 NF-kappa B Proteins 0.000 description 2
• 102000003945 NF-kappa B Human genes 0.000 description 2
• 102400000058 Neuregulin-1 Human genes 0.000 description 2
• 108090000556 Neuregulin-1 Proteins 0.000 description 2
• 102000004108 Neurotransmitter Receptors Human genes 0.000 description 2
• 108090000590 Neurotransmitter Receptors Proteins 0.000 description 2
• 108010070047 Notch Receptors Proteins 0.000 description 2
• 102000005650 Notch Receptors Human genes 0.000 description 2
• 102000018886 Pancreatic Polypeptide Human genes 0.000 description 2
• 241000237509 Patinopecten sp. Species 0.000 description 2
• 229930182555 Penicillin Natural products 0.000 description 2
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
• 208000002387 Popliteal pterygium syndrome Diseases 0.000 description 2
• RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
• 108010029485 Protein Isoforms Proteins 0.000 description 2
• 102000001708 Protein Isoforms Human genes 0.000 description 2
• 101150112172 SBDS gene Proteins 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
• 102100026966 Thrombomodulin Human genes 0.000 description 2
• 108010079274 Thrombomodulin Proteins 0.000 description 2
• 101150027964 ada gene Proteins 0.000 description 2
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
• 201000009628 adenosine deaminase deficiency Diseases 0.000 description 2
• 206010064930 age-related macular degeneration Diseases 0.000 description 2
• 235000010233 benzoic acid Nutrition 0.000 description 2
• QZPQTZZNNJUOLS-UHFFFAOYSA-N beta-lapachone Chemical compound C12=CC=CC=C2C(=O)C(=O)C2=C1OC(C)(C)CC2 QZPQTZZNNJUOLS-UHFFFAOYSA-N 0.000 description 2
• 108091008324 binding proteins Proteins 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 210000000988 bone and bone Anatomy 0.000 description 2
• 210000004899 c-terminal region Anatomy 0.000 description 2
• HIYAVKIYRIFSCZ-UHFFFAOYSA-N calcium ionophore A23187 Natural products N=1C2=C(C(O)=O)C(NC)=CC=C2OC=1CC(C(CC1)C)OC1(C(CC1C)C)OC1C(C)C(=O)C1=CC=CN1 HIYAVKIYRIFSCZ-UHFFFAOYSA-N 0.000 description 2
• DRCMAZOSEIMCHM-UHFFFAOYSA-N capsazepine Chemical compound C1C=2C=C(O)C(O)=CC=2CCCN1C(=S)NCCC1=CC=C(Cl)C=C1 DRCMAZOSEIMCHM-UHFFFAOYSA-N 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 230000021164 cell adhesion Effects 0.000 description 2
• 230000032823 cell division Effects 0.000 description 2
• 230000003915 cell function Effects 0.000 description 2
• 239000000460 chlorine Substances 0.000 description 2
• 230000001713 cholinergic effect Effects 0.000 description 2
• 102000006533 chordin Human genes 0.000 description 2
• 108010008846 chordin Proteins 0.000 description 2
• 210000001136 chorion Anatomy 0.000 description 2
• 238000003776 cleavage reaction Methods 0.000 description 2
• 238000000576 coating method Methods 0.000 description 2
• 238000003235 crystal violet staining Methods 0.000 description 2
• 230000032459 dedifferentiation Effects 0.000 description 2
• 238000012217 deletion Methods 0.000 description 2
• 230000037430 deletion Effects 0.000 description 2
• LTNZEXKYNRNOGT-UHFFFAOYSA-N dequalinium chloride Chemical compound [Cl-].[Cl-].C1=CC=C2[N+](CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)=C(C)C=C(N)C2=C1 LTNZEXKYNRNOGT-UHFFFAOYSA-N 0.000 description 2
• 206010012601 diabetes mellitus Diseases 0.000 description 2
• 229910003460 diamond Inorganic materials 0.000 description 2
• 239000010432 diamond Substances 0.000 description 2
• VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
• XHBVYDAKJHETMP-UHFFFAOYSA-N dorsomorphin Chemical compound C=1C=C(C2=CN3N=CC(=C3N=C2)C=2C=CN=CC=2)C=CC=1OCCN1CCCCC1 XHBVYDAKJHETMP-UHFFFAOYSA-N 0.000 description 2
• 208000016570 early-onset generalized limb-onset dystonia Diseases 0.000 description 2
• 239000012636 effector Substances 0.000 description 2
• 230000013020 embryo development Effects 0.000 description 2
• JROGBPMEKVAPEH-GXGBFOEMSA-N emetine dihydrochloride Chemical compound Cl.Cl.N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC JROGBPMEKVAPEH-GXGBFOEMSA-N 0.000 description 2
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 2
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 2
• 210000005175 epidermal keratinocyte Anatomy 0.000 description 2
• 235000020776 essential amino acid Nutrition 0.000 description 2
• 239000003797 essential amino acid Substances 0.000 description 2
• 230000035611 feeding Effects 0.000 description 2
• 230000004927 fusion Effects 0.000 description 2
• 210000001035 gastrointestinal tract Anatomy 0.000 description 2
• GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 description 2
• 229940049906 glutamate Drugs 0.000 description 2
• 229930195712 glutamate Natural products 0.000 description 2
• 230000002710 gonadal effect Effects 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 102000046645 human LIF Human genes 0.000 description 2
• JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
• RJJLZYZEVNCZIW-UHFFFAOYSA-N hydron;n-[2-(methylamino)ethyl]isoquinoline-5-sulfonamide;dichloride Chemical compound Cl.Cl.N1=CC=C2C(S(=O)(=O)NCCNC)=CC=CC2=C1 RJJLZYZEVNCZIW-UHFFFAOYSA-N 0.000 description 2
• 238000002513 implantation Methods 0.000 description 2
• 239000004615 ingredient Substances 0.000 description 2
• 238000003780 insertion Methods 0.000 description 2
• PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 2
• 210000002660 insulin-secreting cell Anatomy 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 229910052742 iron Inorganic materials 0.000 description 2
• 229960000310 isoleucine Drugs 0.000 description 2
• 230000002147 killing effect Effects 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 230000007774 longterm Effects 0.000 description 2
• 210000004072 lung Anatomy 0.000 description 2
• 238000012423 maintenance Methods 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 239000011159 matrix material Substances 0.000 description 2
• 210000004379 membrane Anatomy 0.000 description 2
• 239000012528 membrane Substances 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 230000000921 morphogenic effect Effects 0.000 description 2
• 210000000663 muscle cell Anatomy 0.000 description 2
• 230000035772 mutation Effects 0.000 description 2
• 229930014626 natural product Natural products 0.000 description 2
• 210000003061 neural cell Anatomy 0.000 description 2
• 238000010899 nucleation Methods 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 239000005022 packaging material Substances 0.000 description 2
• 229940049954 penicillin Drugs 0.000 description 2
• 210000002826 placenta Anatomy 0.000 description 2
• 238000002360 preparation method Methods 0.000 description 2
• 229960002429 proline Drugs 0.000 description 2
• 208000022074 proximal spinal muscular atrophy Diseases 0.000 description 2
• 238000011084 recovery Methods 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 102220064719 rs797044561 Human genes 0.000 description 2
• 235000020637 scallop Nutrition 0.000 description 2
• 230000007017 scission Effects 0.000 description 2
• 239000003001 serine protease inhibitor Substances 0.000 description 2
• 208000002491 severe combined immunodeficiency Diseases 0.000 description 2
• 108091006024 signal transducing proteins Proteins 0.000 description 2
• 102000034285 signal transducing proteins Human genes 0.000 description 2
• 230000019491 signal transduction Effects 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 230000006641 stabilisation Effects 0.000 description 2
• 238000011105 stabilization Methods 0.000 description 2
• 230000003068 static effect Effects 0.000 description 2
• 230000023895 stem cell maintenance Effects 0.000 description 2
• 229960005322 streptomycin Drugs 0.000 description 2
• 230000008093 supporting effect Effects 0.000 description 2
• 230000005062 synaptic transmission Effects 0.000 description 2
• 208000011580 syndromic disease Diseases 0.000 description 2
• 238000003786 synthesis reaction Methods 0.000 description 2
• 210000001541 thymus gland Anatomy 0.000 description 2
• 229930003802 tocotrienol Natural products 0.000 description 2
• 239000011731 tocotrienol Substances 0.000 description 2
• 229940068778 tocotrienols Drugs 0.000 description 2
• 235000019148 tocotrienols Nutrition 0.000 description 2
• 201000001340 torsion dystonia 1 Diseases 0.000 description 2
• FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 229960004295 valine Drugs 0.000 description 2
• 235000019155 vitamin A Nutrition 0.000 description 2
• 239000011719 vitamin A Substances 0.000 description 2
• VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 2
• JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
• ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 2
• NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
• 229910000368 zinc sulfate Inorganic materials 0.000 description 2
• DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
• SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
• GXEKYRXVRROBEV-FBXFSONDSA-N (1r,2s,3r,4s)-7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid Chemical compound C1C[C@@H]2[C@@H](C(O)=O)[C@@H](C(=O)O)[C@H]1O2 GXEKYRXVRROBEV-FBXFSONDSA-N 0.000 description 1
• IENJPSDBNBGIEL-DKWTVANSSA-N (2r)-2-amino-3-chloropropanoic acid;hydrochloride Chemical compound Cl.ClC[C@H](N)C(O)=O IENJPSDBNBGIEL-DKWTVANSSA-N 0.000 description 1
• OQEBIHBLFRADNM-UOWFLXDJSA-N (2r,3r,4r)-2-(hydroxymethyl)pyrrolidine-3,4-diol Chemical compound OC[C@H]1NC[C@@H](O)[C@@H]1O OQEBIHBLFRADNM-UOWFLXDJSA-N 0.000 description 1
• ZJIHMALTJRDNQI-VFQQELCFSA-N (2r,3r,4r,5s)-2-(hydroxymethyl)piperidine-3,4,5-triol;hydrochloride Chemical compound Cl.OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O ZJIHMALTJRDNQI-VFQQELCFSA-N 0.000 description 1
• XGDFITZJGKUSDK-FPFZOWOXSA-N (2s)-2-[[(2r,3r)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid;hydrochloride Chemical compound Cl.CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](O)[C@H](N)CC1=CC=CC=C1 XGDFITZJGKUSDK-FPFZOWOXSA-N 0.000 description 1
• GXEDNWSUKCJLLB-LURJTMIESA-N (2s)-2-amino-4-methylpentane-1-thiol Chemical compound CC(C)C[C@H](N)CS GXEDNWSUKCJLLB-LURJTMIESA-N 0.000 description 1
• WNNNWFKQCKFSDK-BYPYZUCNSA-N (2s)-2-aminopent-4-enoic acid Chemical compound OC(=O)[C@@H](N)CC=C WNNNWFKQCKFSDK-BYPYZUCNSA-N 0.000 description 1
• YSVYWVPJJXVIFM-UHFFFAOYSA-N (3-carboxy-2-octadecanoyloxypropyl)-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC(=O)OC(CC(O)=O)C[N+](C)(C)C YSVYWVPJJXVIFM-UHFFFAOYSA-N 0.000 description 1
• OEBJUDGECLJUTH-FQEVSTJZSA-N (3s)-3-[[5-(benzenesulfonamidomethyl)thiophene-2-carbonyl]amino]-5-[(2-chlorophenyl)methylsulfanyl]-4-oxopentanoic acid Chemical compound N([C@@H](CC(=O)O)C(=O)CSCC=1C(=CC=CC=1)Cl)C(=O)C(S1)=CC=C1CNS(=O)(=O)C1=CC=CC=C1 OEBJUDGECLJUTH-FQEVSTJZSA-N 0.000 description 1
• OKXHJSNMCKNGQC-AWEZNQCLSA-N (3s)-3-[[6-(benzenesulfonamidomethyl)pyridine-3-carbonyl]amino]-4-oxobutanoic acid Chemical compound N1=CC(C(=O)N[C@@H](CC(=O)O)C=O)=CC=C1CNS(=O)(=O)C1=CC=CC=C1 OKXHJSNMCKNGQC-AWEZNQCLSA-N 0.000 description 1
• IVOJLNSQLGMYAO-AWEZNQCLSA-N (3s)-3-[[6-[[(3-methylsulfonylphenyl)sulfonylamino]methyl]pyridine-3-carbonyl]amino]-4-oxobutanoic acid Chemical compound CS(=O)(=O)C1=CC=CC(S(=O)(=O)NCC=2N=CC(=CC=2)C(=O)N[C@@H](CC(O)=O)C=O)=C1 IVOJLNSQLGMYAO-AWEZNQCLSA-N 0.000 description 1
• PQNSMYHJDHIPKV-ZDUSSCGKSA-N (3s)-3-[[6-[[(4-hydroxyphenyl)sulfonylamino]methyl]pyridine-3-carbonyl]amino]-4-oxobutanoic acid Chemical compound N1=CC(C(=O)N[C@@H](CC(=O)O)C=O)=CC=C1CNS(=O)(=O)C1=CC=C(O)C=C1 PQNSMYHJDHIPKV-ZDUSSCGKSA-N 0.000 description 1
• WJYVXARRCUTRBW-HNNXBMFYSA-N (3s)-3-[[6-[[[3-(acetylsulfamoyl)phenyl]sulfonylamino]methyl]pyridine-3-carbonyl]amino]-4-oxobutanoic acid Chemical compound CC(=O)NS(=O)(=O)C1=CC=CC(S(=O)(=O)NCC=2N=CC(=CC=2)C(=O)N[C@@H](CC(O)=O)C=O)=C1 WJYVXARRCUTRBW-HNNXBMFYSA-N 0.000 description 1
• YSLPNYJYCBRIOX-HNNXBMFYSA-N (3s)-3-[[6-[[[3-(methanesulfonamido)phenyl]sulfonylamino]methyl]pyridine-3-carbonyl]amino]-4-oxobutanoic acid Chemical compound CS(=O)(=O)NC1=CC=CC(S(=O)(=O)NCC=2N=CC(=CC=2)C(=O)N[C@@H](CC(O)=O)C=O)=C1 YSLPNYJYCBRIOX-HNNXBMFYSA-N 0.000 description 1
• XJBQVBPGIOOPMP-HNNXBMFYSA-N (3s)-3-[[6-[[[3-(methylsulfonylcarbamoyl)phenyl]sulfonylamino]methyl]pyridine-3-carbonyl]amino]-4-oxobutanoic acid Chemical compound CS(=O)(=O)NC(=O)C1=CC=CC(S(=O)(=O)NCC=2N=CC(=CC=2)C(=O)N[C@@H](CC(O)=O)C=O)=C1 XJBQVBPGIOOPMP-HNNXBMFYSA-N 0.000 description 1
• UMHYHMWMJNTZIX-HNNXBMFYSA-N (3s)-3-[[6-[[[4-(methanesulfonamido)phenyl]sulfonylamino]methyl]pyridine-3-carbonyl]amino]-4-oxobutanoic acid Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1S(=O)(=O)NCC1=CC=C(C(=O)N[C@@H](CC(O)=O)C=O)C=N1 UMHYHMWMJNTZIX-HNNXBMFYSA-N 0.000 description 1
• CUKWUWBLQQDQAC-VEQWQPCFSA-N (3s)-3-amino-4-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s,3s)-1-[[(2s)-1-[(2s)-2-[[(1s)-1-carboxyethyl]carbamoyl]pyrrolidin-1-yl]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-ox Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 CUKWUWBLQQDQAC-VEQWQPCFSA-N 0.000 description 1
• DWMVUTWXNPMAGJ-AWEZNQCLSA-N (3s)-4-oxo-3-[[6-[[[3-(2h-tetrazol-5-yl)phenyl]sulfonylamino]methyl]pyridine-3-carbonyl]amino]butanoic acid Chemical compound N1=CC(C(=O)N[C@@H](CC(=O)O)C=O)=CC=C1CNS(=O)(=O)C1=CC=CC(C2=NNN=N2)=C1 DWMVUTWXNPMAGJ-AWEZNQCLSA-N 0.000 description 1
• HHAHHFFADDXEEC-FQEVSTJZSA-N (3s)-5-[(2-chlorophenyl)methylsulfanyl]-3-[[5-[[(4-hydroxyphenyl)sulfonylamino]methyl]thiophene-2-carbonyl]amino]-4-oxopentanoic acid Chemical compound N([C@@H](CC(=O)O)C(=O)CSCC=1C(=CC=CC=1)Cl)C(=O)C(S1)=CC=C1CNS(=O)(=O)C1=CC=C(O)C=C1 HHAHHFFADDXEEC-FQEVSTJZSA-N 0.000 description 1
• USVOMZAPZHSFMM-FQEVSTJZSA-N (3s)-5-[(2-chlorophenyl)methylsulfanyl]-4-oxo-3-[[5-[[[3-(5-oxo-2h-1,2,4-oxadiazol-3-yl)phenyl]sulfonylamino]methyl]thiophene-2-carbonyl]amino]pentanoic acid Chemical compound N([C@@H](CC(=O)O)C(=O)CSCC=1C(=CC=CC=1)Cl)C(=O)C(S1)=CC=C1CNS(=O)(=O)C(C=1)=CC=CC=1C1=NC(=O)ON1 USVOMZAPZHSFMM-FQEVSTJZSA-N 0.000 description 1
• JKNOYWVMHPMBEL-UNXLUWIOSA-N (3z)-2-amino-4-(3,4,5-trihydroxyphenyl)buta-1,3-diene-1,1,3-tricarbonitrile Chemical compound N#CC(C#N)=C(N)\C(C#N)=C\C1=CC(O)=C(O)C(O)=C1 JKNOYWVMHPMBEL-UNXLUWIOSA-N 0.000 description 1
• DXVJRTIPBNBLLB-BJMVGYQFSA-N (3z)-2-amino-4-(4-hydroxyphenyl)buta-1,3-diene-1,1,3-tricarbonitrile Chemical compound N#CC(C#N)=C(N)\C(C#N)=C\C1=CC=C(O)C=C1 DXVJRTIPBNBLLB-BJMVGYQFSA-N 0.000 description 1
• ZTFGOPUOTATSAL-LZGKLYRASA-N (4r)-4-[(1r,3s,5s,8r,9s,10r,11r,13r,14s,17r)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl]oxolan-2-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H]([C@H]5CC(=O)OC5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 ZTFGOPUOTATSAL-LZGKLYRASA-N 0.000 description 1
• HXNBAOLVPAWYLT-NVNXTCNLSA-N (5z)-5-[[5-bromo-2-[(2-bromophenyl)methoxy]phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one Chemical compound S\1C(=S)NC(=O)C/1=C/C1=CC(Br)=CC=C1OCC1=CC=CC=C1Br HXNBAOLVPAWYLT-NVNXTCNLSA-N 0.000 description 1
• ZULBIBHDIQCNIS-HNCPQSOCSA-N (6s)-6-(4-bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole;oxalic acid Chemical compound OC(=O)C(O)=O.C1=CC(Br)=CC=C1[C@@H]1N=C2SCCN2C1 ZULBIBHDIQCNIS-HNCPQSOCSA-N 0.000 description 1
• DOEWDSDBFRHVAP-KRXBUXKQSA-N (E)-3-tosylacrylonitrile Chemical compound CC1=CC=C(S(=O)(=O)\C=C\C#N)C=C1 DOEWDSDBFRHVAP-KRXBUXKQSA-N 0.000 description 1
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
• MASYAWHPJCQLSW-ZIAGYGMSSA-N (R,R)-5,11-diethyl-5,6,11,12-tetrahydro-2,8-chrysenediol Chemical compound C12=CC=C(O)C=C2C[C@@H](CC)C2=C1[C@H](CC)CC1=CC(O)=CC=C12 MASYAWHPJCQLSW-ZIAGYGMSSA-N 0.000 description 1
• MYKCTDWWIWGLHW-NTEUORMPSA-N (e)-2-(2,3-dihydroindole-1-carbonyl)-3-(3,4-dihydroxyphenyl)prop-2-enenitrile Chemical compound C1=C(O)C(O)=CC=C1\C=C(/C#N)C(=O)N1C2=CC=CC=C2CC1 MYKCTDWWIWGLHW-NTEUORMPSA-N 0.000 description 1
• TTZDOBVWBQXGDC-KPKJPENVSA-N (e)-2-(3,4-dihydroxybenzoyl)-3-(1h-indol-3-yl)prop-2-enenitrile Chemical compound C1=C(O)C(O)=CC=C1C(=O)C(\C#N)=C\C1=CNC2=CC=CC=C12 TTZDOBVWBQXGDC-KPKJPENVSA-N 0.000 description 1
• CANOJKGQDCJDOX-VZUCSPMQSA-N (e)-2-(3,4-dihydroxybenzoyl)-3-(3,4-dihydroxyphenyl)prop-2-enenitrile Chemical compound C1=C(O)C(O)=CC=C1\C=C(/C#N)C(=O)C1=CC=C(O)C(O)=C1 CANOJKGQDCJDOX-VZUCSPMQSA-N 0.000 description 1
• HSRMHXWCTRFVHK-NYYWCZLTSA-N (e)-2-(3,4-dihydroxybenzoyl)-3-(4-hydroxy-3-iodo-5-methoxyphenyl)prop-2-enenitrile Chemical compound IC1=C(O)C(OC)=CC(\C=C(/C#N)C(=O)C=2C=C(O)C(O)=CC=2)=C1 HSRMHXWCTRFVHK-NYYWCZLTSA-N 0.000 description 1
• ZZQHNBGRWRQWFI-XNTDXEJSSA-N (e)-2-cyano-3-(3,4-dihydroxyphenyl)-n-(2-phenylethyl)prop-2-enamide Chemical compound C1=C(O)C(O)=CC=C1\C=C(/C#N)C(=O)NCCC1=CC=CC=C1 ZZQHNBGRWRQWFI-XNTDXEJSSA-N 0.000 description 1
• UMGQVUWXNOJOSJ-KMHUVPDISA-N (e)-2-cyano-3-(3,4-dihydroxyphenyl)-n-[(1r)-1-phenylethyl]prop-2-enamide Chemical compound N([C@H](C)C=1C=CC=CC=1)C(=O)C(\C#N)=C\C1=CC=C(O)C(O)=C1 UMGQVUWXNOJOSJ-KMHUVPDISA-N 0.000 description 1
• UMGQVUWXNOJOSJ-DGGAMASNSA-N (e)-2-cyano-3-(3,4-dihydroxyphenyl)-n-[(1s)-1-phenylethyl]prop-2-enamide Chemical compound N([C@@H](C)C=1C=CC=CC=1)C(=O)C(\C#N)=C\C1=CC=C(O)C(O)=C1 UMGQVUWXNOJOSJ-DGGAMASNSA-N 0.000 description 1
• ZHOKHSGWBNPFQU-GONBZBRSSA-N (e)-2-cyano-n-[3-[[(e)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]propyl]-3-(3,4-dihydroxyphenyl)prop-2-enamide Chemical compound C1=C(O)C(O)=CC=C1\C=C(/C#N)C(=O)NCCCNC(=O)C(\C#N)=C\C1=CC=C(O)C(O)=C1 ZHOKHSGWBNPFQU-GONBZBRSSA-N 0.000 description 1
• PPQJCISYYXZCAE-UHFFFAOYSA-N 1,10-phenanthroline;hydrate Chemical compound O.C1=CN=C2C3=NC=CC=C3C=CC2=C1 PPQJCISYYXZCAE-UHFFFAOYSA-N 0.000 description 1
• FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 1
• UOTMYNBWXDUBNX-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinolin-2-ium;chloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 UOTMYNBWXDUBNX-UHFFFAOYSA-N 0.000 description 1
• FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
• WHBHBVVOGNECLV-OBQKJFGGSA-N 11-deoxycortisol Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 WHBHBVVOGNECLV-OBQKJFGGSA-N 0.000 description 1
• FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
• MAASHDQFQDDECQ-UHFFFAOYSA-N 2,3-bis(2-hydroxyethylthio)naphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(SCCO)=C(SCCO)C(=O)C2=C1 MAASHDQFQDDECQ-UHFFFAOYSA-N 0.000 description 1
• SWELIMKTDYHAOY-UHFFFAOYSA-N 2,4-diamino-6-hydroxypyrimidine Chemical compound NC1=CC(=O)N=C(N)N1 SWELIMKTDYHAOY-UHFFFAOYSA-N 0.000 description 1
• UFSBFVZQJZMIOU-LZQZFOIKSA-N 2,4-dinitrophenyl 2-deoxy-2-fluoro-β-d-allopyranoside Chemical compound F[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFSBFVZQJZMIOU-LZQZFOIKSA-N 0.000 description 1
• DCCYTKKDAZEVLY-UHFFFAOYSA-N 2-(2-oxo-2-thiophen-2-ylethyl)sulfanyl-4,6-dithiophen-2-ylpyridine-3-carbonitrile Chemical compound C=1C=CSC=1C(=O)CSC(C=1C#N)=NC(C=2SC=CC=2)=CC=1C1=CC=CS1 DCCYTKKDAZEVLY-UHFFFAOYSA-N 0.000 description 1
• YZOFLYUAQDJWKV-UHFFFAOYSA-N 2-[(3,4,5-trihydroxyphenyl)methylidene]propanedinitrile Chemical compound OC1=CC(C=C(C#N)C#N)=CC(O)=C1O YZOFLYUAQDJWKV-UHFFFAOYSA-N 0.000 description 1
• DWZFIFZYMHNRRV-UHFFFAOYSA-N 2-[(3,4-dihydroxy-5-methoxyphenyl)methylidene]propanedinitrile Chemical compound COC1=CC(C=C(C#N)C#N)=CC(O)=C1O DWZFIFZYMHNRRV-UHFFFAOYSA-N 0.000 description 1
• VTJXFTPMFYAJJU-UHFFFAOYSA-N 2-[(3,4-dihydroxyphenyl)methylidene]propanedinitrile Chemical compound OC1=CC=C(C=C(C#N)C#N)C=C1O VTJXFTPMFYAJJU-UHFFFAOYSA-N 0.000 description 1
• DUQADSPERJRQBW-UHFFFAOYSA-N 2-[(3-hydroxy-4-nitrophenyl)methylidene]propanedinitrile Chemical compound OC1=CC(C=C(C#N)C#N)=CC=C1[N+]([O-])=O DUQADSPERJRQBW-UHFFFAOYSA-N 0.000 description 1
• VWAGIWCLJAQLAL-UHFFFAOYSA-N 2-[(5-chloronaphthalen-1-yl)sulfonylamino]ethylazanium;chloride Chemical compound [Cl-].C1=CC=C2C(S(=O)(=O)NCC[NH3+])=CC=CC2=C1Cl VWAGIWCLJAQLAL-UHFFFAOYSA-N 0.000 description 1
• GUGJQAFPKZZOIV-UHFFFAOYSA-N 2-[2-(isoquinolin-5-ylsulfonylamino)ethyl]guanidine;hydrochloride Chemical compound Cl.N1=CC=C2C(S(=O)(=O)NCCN=C(N)N)=CC=CC2=C1 GUGJQAFPKZZOIV-UHFFFAOYSA-N 0.000 description 1
• QUJXIMWUJGTUEG-CLKUPZDLSA-N 2-[2-[[[(2s,6s,9e,13s)-13-amino-2-[(4-hydroxyphenyl)methyl]-4,14-dioxo-1,5-diazacyclotetradec-9-ene-6-carbonyl]amino]methyl]phenyl]acetic acid Chemical compound C([C@H]1CC(=O)N[C@@H](CC/C=C/CC[C@@H](C(N1)=O)N)C(=O)NCC=1C(=CC=CC=1)CC(O)=O)C1=CC=C(O)C=C1 QUJXIMWUJGTUEG-CLKUPZDLSA-N 0.000 description 1
• KWTQSFXGGICVPE-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)pentanoic acid;hydron;chloride Chemical compound Cl.OC(=O)C(N)CCCN=C(N)N KWTQSFXGGICVPE-UHFFFAOYSA-N 0.000 description 1
• WSLTYZVXORBNLB-UHFFFAOYSA-N 2-benzhydryl-n-[(2-iodophenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine Chemical compound IC1=CC=CC=C1CNC1C(C(C=2C=CC=CC=2)C=2C=CC=CC=2)N2CCC1CC2 WSLTYZVXORBNLB-UHFFFAOYSA-N 0.000 description 1
• OQZQSRICUOWBLW-UHFFFAOYSA-N 2-morpholin-4-yl-8-phenylchromen-4-one;hydrochloride Chemical compound Cl.C1=CC=C2C(=O)C=C(N3CCOCC3)OC2=C1C1=CC=CC=C1 OQZQSRICUOWBLW-UHFFFAOYSA-N 0.000 description 1
• GDCXPZPXAWTYJM-LDXVYITESA-N 2-n-[(1r,2s)-2-aminocyclohexyl]-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine;hydrochloride Chemical compound Cl.N1=C(N[C@H]2[C@H](CCCC2)N)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 GDCXPZPXAWTYJM-LDXVYITESA-N 0.000 description 1
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
• SUGXUUGGLDCZKB-UHFFFAOYSA-N 3,4-dichloroisocoumarin Chemical compound C1=CC=C2C(Cl)=C(Cl)OC(=O)C2=C1 SUGXUUGGLDCZKB-UHFFFAOYSA-N 0.000 description 1
• VXMYWVMXSWJFCV-UHFFFAOYSA-N 3-(4-imidazol-1-ylphenyl)-4,5-dihydro-1h-pyridazin-6-one Chemical compound N1C(=O)CCC(C=2C=CC(=CC=2)N2C=NC=C2)=N1 VXMYWVMXSWJFCV-UHFFFAOYSA-N 0.000 description 1
• ZCFFYALKHPIRKJ-UHFFFAOYSA-N 3-[18-(2-carboxylatoethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-21,24-diium-2-yl]propanoate Chemical compound N1C(C=C2C(=C(C)C(=CC=3C(C)=C(CCC(O)=O)C(N=3)=C3)N2)C=C)=C(C)C(C=C)=C1C=C1C(C)=C(CCC(O)=O)C3=N1 ZCFFYALKHPIRKJ-UHFFFAOYSA-N 0.000 description 1
• ZCNBZFRECRPCKU-UHFFFAOYSA-N 3-[2-[4-[bis(4-fluorophenyl)methylidene]-1-piperidinyl]ethyl]-2-sulfanylidene-1H-quinazolin-4-one Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)=C1CCN(CCN2C(C3=CC=CC=C3NC2=S)=O)CC1 ZCNBZFRECRPCKU-UHFFFAOYSA-N 0.000 description 1
• MENAYYMPBRSAAE-AWEZNQCLSA-N 3-[[5-[[(2s)-1-carboxy-3-oxopropan-2-yl]carbamoyl]pyridin-2-yl]methylsulfamoyl]benzoic acid Chemical compound N1=CC(C(=O)N[C@@H](CC(=O)O)C=O)=CC=C1CNS(=O)(=O)C1=CC=CC(C(O)=O)=C1 MENAYYMPBRSAAE-AWEZNQCLSA-N 0.000 description 1
• GAMKNLFIHBMGQT-UHFFFAOYSA-N 3-hexadecanoyloxy-4-(trimethylazaniumyl)butanoate;hydrochloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC(=O)OC(CC(O)=O)C[N+](C)(C)C GAMKNLFIHBMGQT-UHFFFAOYSA-N 0.000 description 1
• HUJXGQILHAUCCV-MOROJQBDSA-N 3-iodobenzyl-5'-N-methylcarboxamidoadenosine Chemical compound O[C@@H]1[C@H](O)[C@@H](C(=O)NC)O[C@H]1N1C2=NC=NC(NCC=3C=C(I)C=CC=3)=C2N=C1 HUJXGQILHAUCCV-MOROJQBDSA-N 0.000 description 1
• LOEIRDBRYBHAJB-UHFFFAOYSA-N 4,5,6,7-tetrabromo-1h-benzimidazole Chemical compound BrC1=C(Br)C(Br)=C2NC=NC2=C1Br LOEIRDBRYBHAJB-UHFFFAOYSA-N 0.000 description 1
• AAALVYBICLMAMA-UHFFFAOYSA-N 4,5-dianilinophthalimide Chemical compound C=1C=CC=CC=1NC=1C=C2C(=O)NC(=O)C2=CC=1NC1=CC=CC=C1 AAALVYBICLMAMA-UHFFFAOYSA-N 0.000 description 1
• RRZVGDGTWNQAPW-UHFFFAOYSA-N 4-[5-(1-methylpyrazol-4-yl)-3-[2-(1-methylpyrazol-4-yl)ethyl]imidazol-4-yl]benzonitrile Chemical compound C1=NN(C)C=C1CCN1C(C=2C=CC(=CC=2)C#N)=C(C2=CN(C)N=C2)N=C1 RRZVGDGTWNQAPW-UHFFFAOYSA-N 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• PVWNFAGYFUUDRC-UHFFFAOYSA-N 4-amino-5-formamidomethyl-2-methylpyrimidine Chemical compound CC1=NC=C(CNC=O)C(N)=N1 PVWNFAGYFUUDRC-UHFFFAOYSA-N 0.000 description 1
• JJCDCMDVPYDUEU-UHFFFAOYSA-N 4-chloro-1-(4-methylphenyl)pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(C)=CC=C1N1C2=NC=NC(Cl)=C2C=N1 JJCDCMDVPYDUEU-UHFFFAOYSA-N 0.000 description 1
• ZMZGIVVRBMFZSG-UHFFFAOYSA-N 4-hydroxybenzohydrazide Chemical compound NNC(=O)C1=CC=C(O)C=C1 ZMZGIVVRBMFZSG-UHFFFAOYSA-N 0.000 description 1
• MQWCXKGKQLNYQG-UHFFFAOYSA-N 4-methylcyclohexan-1-ol Chemical compound CC1CCC(O)CC1 MQWCXKGKQLNYQG-UHFFFAOYSA-N 0.000 description 1
• 125000001417 5'-guanylyl group Chemical group C=12N=C(N([H])[H])N([H])C(=O)C=1N=C([H])N2[C@@]1([H])[C@@](O[H])([H])[C@@](O[H])([H])[C@](C(OP(=O)(O[H])[*])([H])[H])([H])O1 0.000 description 1
• FPWXVWZFQXQWTH-UHFFFAOYSA-N 5-(3-chloroanilino)-N-(2-hydroxyethyl)benzo[c][2,6]naphthyridine-8-carboxamide Chemical compound ClC=1C=C(C=CC=1)NC1=NC2=C(C3=CN=CC=C13)C=CC(=C2)C(=O)NCCO FPWXVWZFQXQWTH-UHFFFAOYSA-N 0.000 description 1
• QHKQIPCBIONNNA-SFHVURJKSA-N 5-[[5-[[(2s)-1-carboxy-3-oxo-4-(pyridin-3-ylmethylsulfanyl)butan-2-yl]carbamoyl]thiophen-2-yl]methylsulfamoyl]-2-hydroxybenzoic acid Chemical compound N([C@@H](CC(=O)O)C(=O)CSCC=1C=NC=CC=1)C(=O)C(S1)=CC=C1CNS(=O)(=O)C1=CC=C(O)C(C(O)=O)=C1 QHKQIPCBIONNNA-SFHVURJKSA-N 0.000 description 1
• YRPYWPSDJUJBQH-SFHVURJKSA-N 5-[[5-[[(2s)-1-carboxy-3-oxo-4-(pyridin-4-ylmethylsulfanyl)butan-2-yl]carbamoyl]thiophen-2-yl]methylsulfamoyl]-2-hydroxybenzoic acid Chemical compound N([C@@H](CC(=O)O)C(=O)CSCC=1C=CN=CC=1)C(=O)C(S1)=CC=C1CNS(=O)(=O)C1=CC=C(O)C(C(O)=O)=C1 YRPYWPSDJUJBQH-SFHVURJKSA-N 0.000 description 1
• IAZHUZNOJTUKSY-FQEVSTJZSA-N 5-[[5-[[(2s)-1-carboxy-3-oxo-6-phenylhexan-2-yl]carbamoyl]thiophen-2-yl]methylsulfamoyl]-2-hydroxybenzoic acid Chemical compound N([C@@H](CC(=O)O)C(=O)CCCC=1C=CC=CC=1)C(=O)C(S1)=CC=C1CNS(=O)(=O)C1=CC=C(O)C(C(O)=O)=C1 IAZHUZNOJTUKSY-FQEVSTJZSA-N 0.000 description 1
• MKCPZCBJTCEQFQ-FQEVSTJZSA-N 5-[[5-[[(2s)-1-carboxy-4-[(2-chlorophenyl)methylsulfanyl]-3-oxobutan-2-yl]carbamoyl]thiophen-2-yl]methyl-methylsulfamoyl]-2-hydroxybenzoic acid Chemical compound O=C([C@H](CC(O)=O)NC(=O)C1=CC=C(S1)CN(C)S(=O)(=O)C=1C=C(C(O)=CC=1)C(O)=O)CSCC1=CC=CC=C1Cl MKCPZCBJTCEQFQ-FQEVSTJZSA-N 0.000 description 1
• QAQDHNYHJFERKX-HNNXBMFYSA-N 5-[[5-[[(2s)-1-carboxy-4-methylsulfanyl-3-oxobutan-2-yl]carbamoyl]pyridin-2-yl]methylsulfamoyl]-2-hydroxybenzoic acid Chemical compound N1=CC(C(=O)N[C@@H](CC(O)=O)C(=O)CSC)=CC=C1CNS(=O)(=O)C1=CC=C(O)C(C(O)=O)=C1 QAQDHNYHJFERKX-HNNXBMFYSA-N 0.000 description 1
• VANHQTOUHVZHHF-IBGZPJMESA-N 5-[[5-[[(2s)-3-carboxy-1-[5-(2,6-dichlorophenyl)-1,3-oxazol-2-yl]-1-oxopropan-2-yl]carbamoyl]pyridin-2-yl]methylsulfamoyl]-2-hydroxybenzoic acid Chemical compound N([C@@H](CC(=O)O)C(=O)C=1OC(=CN=1)C=1C(=CC=CC=1Cl)Cl)C(=O)C(C=N1)=CC=C1CNS(=O)(=O)C1=CC=C(O)C(C(O)=O)=C1 VANHQTOUHVZHHF-IBGZPJMESA-N 0.000 description 1
• QNOXYUNHIGOWNY-UHFFFAOYSA-N 6,7-dimethoxy-2-phenylquinoxaline Chemical compound N1=C2C=C(OC)C(OC)=CC2=NC=C1C1=CC=CC=C1 QNOXYUNHIGOWNY-UHFFFAOYSA-N 0.000 description 1
• MFVJXLPANKSLLD-UHFFFAOYSA-N 6-[2-[4-[(4-fluorophenyl)-phenylmethylidene]-1-piperidinyl]ethyl]-7-methyl-5-thiazolo[3,2-a]pyrimidinone Chemical compound CC=1N=C2SC=CN2C(=O)C=1CCN(CC1)CCC1=C(C=1C=CC(F)=CC=1)C1=CC=CC=C1 MFVJXLPANKSLLD-UHFFFAOYSA-N 0.000 description 1
• 101710187795 60S ribosomal protein L15 Proteins 0.000 description 1
• ATEFPOUAMCWAQS-UHFFFAOYSA-N 7,8-dihydroxycoumarin Chemical compound C1=CC(=O)OC2=C(O)C(O)=CC=C21 ATEFPOUAMCWAQS-UHFFFAOYSA-N 0.000 description 1
• HFDKKNHCYWNNNQ-YOGANYHLSA-N 75976-10-2 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C1=CC=C(O)C=C1 HFDKKNHCYWNNNQ-YOGANYHLSA-N 0.000 description 1
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
• WRDABNWSWOHGMS-UHFFFAOYSA-N AEBSF hydrochloride Chemical compound Cl.NCCC1=CC=C(S(F)(=O)=O)C=C1 WRDABNWSWOHGMS-UHFFFAOYSA-N 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• 239000005660 Abamectin Substances 0.000 description 1
• LPMXVESGRSUGHW-UHFFFAOYSA-N Acolongiflorosid K Natural products OC1C(O)C(O)C(C)OC1OC1CC2(O)CCC3C4(O)CCC(C=5COC(=O)C=5)C4(C)CC(O)C3C2(CO)C(O)C1 LPMXVESGRSUGHW-UHFFFAOYSA-N 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 108010059616 Activins Proteins 0.000 description 1
• 102000005606 Activins Human genes 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• 102400000345 Angiotensin-2 Human genes 0.000 description 1
• 101800000733 Angiotensin-2 Proteins 0.000 description 1
• 244000105975 Antidesma platyphyllum Species 0.000 description 1
• 108020005544 Antisense RNA Proteins 0.000 description 1
• 101100331289 Aquifex aeolicus (strain VF5) der gene Proteins 0.000 description 1
• 101000767534 Arabidopsis thaliana Chorismate mutase 2 Proteins 0.000 description 1
• 101000993093 Arabidopsis thaliana Heat stress transcription factor B-2a Proteins 0.000 description 1
• 241000501754 Astronotus ocellatus Species 0.000 description 1
• XHVAWZZCDCWGBK-WYRLRVFGSA-M Aurothioglucose Chemical compound OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O XHVAWZZCDCWGBK-WYRLRVFGSA-M 0.000 description 1
• 239000012583 B-27 Supplement Substances 0.000 description 1
• XGDFITZJGKUSDK-UDYGKFQRSA-N Bestatin (hydrochloride) Chemical compound Cl.CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1 XGDFITZJGKUSDK-UDYGKFQRSA-N 0.000 description 1
• 102100026031 Beta-glucuronidase Human genes 0.000 description 1
• 101100454434 Biomphalaria glabrata BG04 gene Proteins 0.000 description 1
• ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
• 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 1
• 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
• AYNSTGCNKVUQIL-UHFFFAOYSA-N C(CCCCCCCCCCC)C=1C=CC(=C(C=1)C1=NC(=CC(=C1)N(CCN(C)C)C)C1=C(C=CC(=C1)CCCCCCCCCCCC)OC)OC Chemical compound C(CCCCCCCCCCC)C=1C=CC(=C(C=1)C1=NC(=CC(=C1)N(CCN(C)C)C)C1=C(C=CC(=C1)CCCCCCCCCCCC)OC)OC AYNSTGCNKVUQIL-UHFFFAOYSA-N 0.000 description 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
• KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 1
• 101000722824 Caenorhabditis elegans Dauer abnormal formation protein 25 Proteins 0.000 description 1
• 101100388509 Caenorhabditis elegans che-3 gene Proteins 0.000 description 1
• 101100459896 Caenorhabditis elegans ncl-1 gene Proteins 0.000 description 1
• 101100356682 Caenorhabditis elegans rho-1 gene Proteins 0.000 description 1
• 101100257359 Caenorhabditis elegans sox-2 gene Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 102000003922 Calcium Channels Human genes 0.000 description 1
• 108090000312 Calcium Channels Proteins 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 102100021753 Cardiolipin synthase (CMP-forming) Human genes 0.000 description 1
• 208000024172 Cardiovascular disease Diseases 0.000 description 1
• 108090000994 Catalytic RNA Proteins 0.000 description 1
• 102000053642 Catalytic RNA Human genes 0.000 description 1
• VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
• 102000011068 Cdc42 Human genes 0.000 description 1
• 108050001278 Cdc42 Proteins 0.000 description 1
• 102000000844 Cell Surface Receptors Human genes 0.000 description 1
• 108010001857 Cell Surface Receptors Proteins 0.000 description 1
• 241000202252 Cerberus Species 0.000 description 1
• 102100025745 Cerberus Human genes 0.000 description 1
• 101710010675 Cerberus Proteins 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• 102000011045 Chloride Channels Human genes 0.000 description 1
• 108010062745 Chloride Channels Proteins 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
• 108010077544 Chromatin Proteins 0.000 description 1
• VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
• 208000028952 Chronic enteropathy associated with SLCO2A1 gene Diseases 0.000 description 1
• PHEDXBVPIONUQT-UHFFFAOYSA-N Cocarcinogen A1 Natural products CCCCCCCCCCCCCC(=O)OC1C(C)C2(O)C3C=C(C)C(=O)C3(O)CC(CO)=CC2C2C1(OC(C)=O)C2(C)C PHEDXBVPIONUQT-UHFFFAOYSA-N 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
• MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
• MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
• IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
• 229930105110 Cyclosporin A Natural products 0.000 description 1
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
• 108010036949 Cyclosporine Proteins 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
• ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
• OQEBIHBLFRADNM-UHFFFAOYSA-N D-iminoxylitol Natural products OCC1NCC(O)C1O OQEBIHBLFRADNM-UHFFFAOYSA-N 0.000 description 1
• 108091065053 DAN family Proteins 0.000 description 1
• 102000038900 DAN family Human genes 0.000 description 1
• 230000033616 DNA repair Effects 0.000 description 1
• SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 1
• 102100036949 Developmental pluripotency-associated protein 2 Human genes 0.000 description 1
• 101000582926 Dictyostelium discoideum Probable serine/threonine-protein kinase PLK Proteins 0.000 description 1
• 102100022317 Dihydropteridine reductase Human genes 0.000 description 1
• IOIMDJXKIMCMIG-UHFFFAOYSA-N Diphosphoramide, N,N',N'',N'''-tetrakis(1-methylethyl)- Chemical compound CC(C)NP(=O)(NC(C)C)OP(=O)(NC(C)C)NC(C)C IOIMDJXKIMCMIG-UHFFFAOYSA-N 0.000 description 1
• 101150059079 EBNA1 gene Proteins 0.000 description 1
• 102000001301 EGF receptor Human genes 0.000 description 1
• 108060006698 EGF receptor Proteins 0.000 description 1
• 201000009051 Embryonal Carcinoma Diseases 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 239000010282 Emodin Substances 0.000 description 1
• RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
• 102100039328 Endoplasmin Human genes 0.000 description 1
• 102400000686 Endothelin-1 Human genes 0.000 description 1
• 101800004490 Endothelin-1 Proteins 0.000 description 1
• 102400001368 Epidermal growth factor Human genes 0.000 description 1
• 101800003838 Epidermal growth factor Proteins 0.000 description 1
• 241000283073 Equus caballus Species 0.000 description 1
• 101100129915 Escherichia coli (strain K12) melB gene Proteins 0.000 description 1
• DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
• 101150021185 FGF gene Proteins 0.000 description 1
• 101150081880 FGF1 gene Proteins 0.000 description 1
• 241000282324 Felis Species 0.000 description 1
• 239000004277 Ferrous carbonate Substances 0.000 description 1
• 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
• 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 1
• 102100024802 Fibroblast growth factor 23 Human genes 0.000 description 1
• 102100028043 Fibroblast growth factor 3 Human genes 0.000 description 1
• 102100037680 Fibroblast growth factor 8 Human genes 0.000 description 1
• 102000016970 Follistatin Human genes 0.000 description 1
• 108010014612 Follistatin Proteins 0.000 description 1
• VWUXBMIQPBEWFH-WCCTWKNTSA-N Fulvestrant Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC2=C1 VWUXBMIQPBEWFH-WCCTWKNTSA-N 0.000 description 1
• 108091006027 G proteins Proteins 0.000 description 1
• 102000030782 GTP binding Human genes 0.000 description 1
• 108091000058 GTP-Binding Proteins 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 108010051975 Glycogen Synthase Kinase 3 beta Proteins 0.000 description 1
• 102100038104 Glycogen synthase kinase-3 beta Human genes 0.000 description 1
• 229930186217 Glycolipid Natural products 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 102100038367 Gremlin-1 Human genes 0.000 description 1
• 102100032606 Heat shock factor protein 1 Human genes 0.000 description 1
• 101710190344 Heat shock factor protein 1 Proteins 0.000 description 1
• YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
• 101150094793 Hes3 gene Proteins 0.000 description 1
• 101150029234 Hes5 gene Proteins 0.000 description 1
• 102100028098 Homeobox protein Nkx-6.1 Human genes 0.000 description 1
• 101000684275 Homo sapiens ADP-ribosylation factor 3 Proteins 0.000 description 1
• 101000933465 Homo sapiens Beta-glucuronidase Proteins 0.000 description 1
• 101000895518 Homo sapiens Cardiolipin synthase (CMP-forming) Proteins 0.000 description 1
• 101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 description 1
• 101000804948 Homo sapiens Developmental pluripotency-associated protein 2 Proteins 0.000 description 1
• 101000902365 Homo sapiens Dihydropteridine reductase Proteins 0.000 description 1
• 101000812663 Homo sapiens Endoplasmin Proteins 0.000 description 1
• 101000896557 Homo sapiens Eukaryotic translation initiation factor 3 subunit B Proteins 0.000 description 1
• 101001051973 Homo sapiens Fibroblast growth factor 23 Proteins 0.000 description 1
• 101001060280 Homo sapiens Fibroblast growth factor 3 Proteins 0.000 description 1
• 101001027382 Homo sapiens Fibroblast growth factor 8 Proteins 0.000 description 1
• 101001032872 Homo sapiens Gremlin-1 Proteins 0.000 description 1
• 101000988834 Homo sapiens Hypoxanthine-guanine phosphoribosyltransferase Proteins 0.000 description 1
• 101000998969 Homo sapiens Inositol-3-phosphate synthase 1 Proteins 0.000 description 1
• 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 description 1
• 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
• 101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 description 1
• 101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 description 1
• 101000734650 Homo sapiens Programmed cell death protein 7 Proteins 0.000 description 1
• 101000799554 Homo sapiens Protein AATF Proteins 0.000 description 1
• 101000836765 Homo sapiens Protein amnionless Proteins 0.000 description 1
• 101001110286 Homo sapiens Ras-related C3 botulinum toxin substrate 1 Proteins 0.000 description 1
• 101001130437 Homo sapiens Ras-related protein Rap-2b Proteins 0.000 description 1
• 101000669921 Homo sapiens Rho-associated protein kinase 2 Proteins 0.000 description 1
• 101000666657 Homo sapiens Rho-related GTP-binding protein RhoQ Proteins 0.000 description 1
• 101100310647 Homo sapiens SOX17 gene Proteins 0.000 description 1
• 101000843556 Homo sapiens Transcription factor HES-1 Proteins 0.000 description 1
• 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 description 1
• 101000777245 Homo sapiens Undifferentiated embryonic cell transcription factor 1 Proteins 0.000 description 1
• 101000851018 Homo sapiens Vascular endothelial growth factor receptor 1 Proteins 0.000 description 1
• 101000784538 Homo sapiens Zinc finger and SCAN domain-containing protein 10 Proteins 0.000 description 1
• 101100141719 Human cytomegalovirus (strain Merlin) RL13 gene Proteins 0.000 description 1
• AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
• DOMWKUIIPQCAJU-LJHIYBGHSA-N Hydroxyprogesterone caproate Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)CCCCC)[C@@]1(C)CC2 DOMWKUIIPQCAJU-LJHIYBGHSA-N 0.000 description 1
• 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 1
• 101150088952 IGF1 gene Proteins 0.000 description 1
• ZJVFLBOZORBYFE-UHFFFAOYSA-N Ibudilast Chemical compound C1=CC=CC2=C(C(=O)C(C)C)C(C(C)C)=NN21 ZJVFLBOZORBYFE-UHFFFAOYSA-N 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
• 102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 1
• 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 1
• 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
• 102000015696 Interleukins Human genes 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• 206010022998 Irritability Diseases 0.000 description 1
• 239000007760 Iscove's Modified Dulbecco's Medium Substances 0.000 description 1
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
• 102000011782 Keratins Human genes 0.000 description 1
• 108010076876 Keratins Proteins 0.000 description 1
• 208000017924 Klinefelter Syndrome Diseases 0.000 description 1
• QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
• CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
• FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• 239000004201 L-cysteine Substances 0.000 description 1
• 235000013878 L-cysteine Nutrition 0.000 description 1
• LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
• 239000004158 L-cystine Substances 0.000 description 1
• 235000019393 L-cystine Nutrition 0.000 description 1
• 239000004395 L-leucine Substances 0.000 description 1
• 235000019454 L-leucine Nutrition 0.000 description 1
• BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• 229930195722 L-methionine Natural products 0.000 description 1
• UVSVTDVJQAJIFG-VURMDHGXSA-N LFM-A13 Chemical compound C\C(O)=C(/C#N)C(=O)NC1=CC(Br)=CC=C1Br UVSVTDVJQAJIFG-VURMDHGXSA-N 0.000 description 1
• QDLHCMPXEPAAMD-ZGSWIPFCSA-N LSM-1318 Chemical compound C1([C@]2(C)C3=C(C4=O)OC=C3C(=O)O[C@@H]2COC)=C4C2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O QDLHCMPXEPAAMD-ZGSWIPFCSA-N 0.000 description 1
• GAAKALASJNGQKD-UHFFFAOYSA-N LY-165163 Chemical compound C1=CC(N)=CC=C1CCN1CCN(C=2C=C(C=CC=2)C(F)(F)F)CC1 GAAKALASJNGQKD-UHFFFAOYSA-N 0.000 description 1
• WMFYOYKPJLRMJI-UHFFFAOYSA-N Lercanidipine hydrochloride Chemical compound Cl.COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 WMFYOYKPJLRMJI-UHFFFAOYSA-N 0.000 description 1
• 208000009625 Lesch-Nyhan syndrome Diseases 0.000 description 1
• HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
• LAZPBGZRMVRFKY-HNCPQSOCSA-N Levamisole hydrochloride Chemical compound Cl.C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 LAZPBGZRMVRFKY-HNCPQSOCSA-N 0.000 description 1
• 108090001030 Lipoproteins Proteins 0.000 description 1
• 102000004895 Lipoproteins Human genes 0.000 description 1
• 239000000867 Lipoxygenase Inhibitor Substances 0.000 description 1
• 229940122142 Lipoxygenase inhibitor Drugs 0.000 description 1
• 102000003820 Lipoxygenases Human genes 0.000 description 1
• 108090000128 Lipoxygenases Proteins 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• MZOPWQKISXCCTP-UHFFFAOYSA-N Malonoben Chemical compound CC(C)(C)C1=CC(C=C(C#N)C#N)=CC(C(C)(C)C)=C1O MZOPWQKISXCCTP-UHFFFAOYSA-N 0.000 description 1
• YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
• HBNPJJILLOYFJU-VMPREFPWSA-N Mibefradil Chemical compound C1CC2=CC(F)=CC=C2[C@H](C(C)C)[C@@]1(OC(=O)COC)CCN(C)CCCC1=NC2=CC=CC=C2N1 HBNPJJILLOYFJU-VMPREFPWSA-N 0.000 description 1
• 101710142315 Mitochondrial antiviral-signaling protein Proteins 0.000 description 1
• 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 1
• 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 1
• 102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 1
• 101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 1
• 101100286123 Mus musculus Hoxa1 gene Proteins 0.000 description 1
• 101100351017 Mus musculus Pax4 gene Proteins 0.000 description 1
• 101100310648 Mus musculus Sox17 gene Proteins 0.000 description 1
• 101100257363 Mus musculus Sox2 gene Proteins 0.000 description 1
• 102100026784 Myelin proteolipid protein Human genes 0.000 description 1
• IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
• ZYFVLHYHXNFROE-KRWDZBQOSA-N N'-[(5S)-1-(hydroxyamino)-1-oxononan-5-yl]-N-phenylhexanediamide Chemical compound ONC(CCC[C@H](CCCC)NC(CCCCC(=O)NC1=CC=CC=C1)=O)=O ZYFVLHYHXNFROE-KRWDZBQOSA-N 0.000 description 1
• QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
• IJNCJYJSEFDKFC-UHFFFAOYSA-N N-[[4-methoxy-2-(trifluoromethyl)phenyl]methyl]-1-propanoylpiperidine-4-carboxamide Chemical compound COC1=CC(=C(CNC(=O)C2CCN(CC2)C(CC)=O)C=C1)C(F)(F)F IJNCJYJSEFDKFC-UHFFFAOYSA-N 0.000 description 1
• MQUQNUAYKLCRME-INIZCTEOSA-N N-tosyl-L-phenylalanyl chloromethyl ketone Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N[C@H](C(=O)CCl)CC1=CC=CC=C1 MQUQNUAYKLCRME-INIZCTEOSA-N 0.000 description 1
• 101150012532 NANOG gene Proteins 0.000 description 1
• BCCQNBXHUMKLFW-HNQRYHMESA-N NNC 55-0396 dihydrochloride Chemical compound Cl.Cl.O([C@]1(CCN(C)CCCC=2NC3=CC=CC=C3N=2)CCC2=CC(F)=CC=C2[C@@H]1C(C)C)C(=O)C1CC1 BCCQNBXHUMKLFW-HNQRYHMESA-N 0.000 description 1
• 101000986989 Naja kaouthia Acidic phospholipase A2 CM-II Proteins 0.000 description 1
• 208000009905 Neurofibromatoses Diseases 0.000 description 1
• 101100205180 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-6 gene Proteins 0.000 description 1
• 101100519293 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pdx-1 gene Proteins 0.000 description 1
• 102100037369 Nidogen-1 Human genes 0.000 description 1
• 239000004677 Nylon Substances 0.000 description 1
• 101150092239 OTX2 gene Proteins 0.000 description 1
• 239000005642 Oleic acid Substances 0.000 description 1
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 108700020796 Oncogene Proteins 0.000 description 1
• 102000043276 Oncogene Human genes 0.000 description 1
• LPMXVESGRSUGHW-GHYGWZAOSA-N Ouabain Natural products O([C@@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1)[C@H]1C[C@@H](O)[C@@]2(CO)[C@@](O)(C1)CC[C@H]1[C@]3(O)[C@@](C)([C@H](C4=CC(=O)OC4)CC3)C[C@@H](O)[C@H]21 LPMXVESGRSUGHW-GHYGWZAOSA-N 0.000 description 1
• 208000012868 Overgrowth Diseases 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 101710144033 Pancreas/duodenum homeobox protein 1 Proteins 0.000 description 1
• 208000018737 Parkinson disease Diseases 0.000 description 1
• 208000017493 Pelizaeus-Merzbacher disease Diseases 0.000 description 1
• 208000019181 Pelizaeus-Merzbacher-like disease Diseases 0.000 description 1
• 241000228143 Penicillium Species 0.000 description 1
• BYPFEZZEUUWMEJ-UHFFFAOYSA-N Pentoxifylline Chemical compound O=C1N(CCCCC(=O)C)C(=O)N(C)C2=C1N(C)C=N2 BYPFEZZEUUWMEJ-UHFFFAOYSA-N 0.000 description 1
• 206010034832 Pharyngeal pouch Diseases 0.000 description 1
• IIXHQGSINFQLRR-UHFFFAOYSA-N Piceatannol Natural products Oc1ccc(C=Cc2c(O)c(O)c3CCCCc3c2O)cc1O IIXHQGSINFQLRR-UHFFFAOYSA-N 0.000 description 1
• 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 description 1
• 102000010995 Pleckstrin homology domains Human genes 0.000 description 1
• 108050001185 Pleckstrin homology domains Proteins 0.000 description 1
• 108010039918 Polylysine Proteins 0.000 description 1
• 241001417524 Pomacanthidae Species 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 244000028344 Primula vulgaris Species 0.000 description 1
• 235000016311 Primula vulgaris Nutrition 0.000 description 1
• 102100034694 Programmed cell death protein 7 Human genes 0.000 description 1
• 102100034180 Protein AATF Human genes 0.000 description 1
• 101710150336 Protein Rex Proteins 0.000 description 1
• 102100027097 Protein amnionless Human genes 0.000 description 1
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
• 108010067787 Proteoglycans Proteins 0.000 description 1
• 102000016611 Proteoglycans Human genes 0.000 description 1
• 101150111584 RHOA gene Proteins 0.000 description 1
• 108091030071 RNAI Proteins 0.000 description 1
• 101150085390 RPM1 gene Proteins 0.000 description 1
• 102100022122 Ras-related C3 botulinum toxin substrate 1 Human genes 0.000 description 1
• 102100031421 Ras-related protein Rap-2b Human genes 0.000 description 1
• 101100016889 Rattus norvegicus Hes2 gene Proteins 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
• 102100039314 Rho-associated protein kinase 2 Human genes 0.000 description 1
• 102100038339 Rho-related GTP-binding protein RhoQ Human genes 0.000 description 1
• 101150054980 Rhob gene Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• LHHQTXPEHJNOCX-UHFFFAOYSA-N Rottlerin Natural products CC(=O)c1c(O)c(C)c(O)c(Oc2c(O)c3C=CC(C)(C)Cc3c(C(=O)C=Cc4ccccc4)c2O)c1O LHHQTXPEHJNOCX-UHFFFAOYSA-N 0.000 description 1
• GKGKBZYMDILCOF-UHFFFAOYSA-N SB 224289 hydrochloride Chemical compound Cl.C1CN(C)CCC11C2=CC(N(C(=O)C=3C=CC(=CC=3)C=3C(=CC(=CC=3)C=3N=C(C)ON=3)C)CC3)=C3C=C2OC1 GKGKBZYMDILCOF-UHFFFAOYSA-N 0.000 description 1
• 101150007417 SOX17 gene Proteins 0.000 description 1
• 101100385368 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CSG2 gene Proteins 0.000 description 1
• 108020004459 Small interfering RNA Proteins 0.000 description 1
• 229910008066 SnC12 Inorganic materials 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• 102000007637 Soluble Guanylyl Cyclase Human genes 0.000 description 1
• 108010007205 Soluble Guanylyl Cyclase Proteins 0.000 description 1
• 102000005157 Somatostatin Human genes 0.000 description 1
• 108010056088 Somatostatin Proteins 0.000 description 1
• 101150001847 Sox15 gene Proteins 0.000 description 1
• 229930182558 Sterol Natural products 0.000 description 1
• 241001468227 Streptomyces avermitilis Species 0.000 description 1
• 244000166550 Strophanthus gratus Species 0.000 description 1
• 101000983124 Sus scrofa Pancreatic prohormone precursor Proteins 0.000 description 1
• 102100028706 Synaptophysin Human genes 0.000 description 1
• 102000003141 Tachykinin Human genes 0.000 description 1
• 102100038126 Tenascin Human genes 0.000 description 1
• 108010008125 Tenascin Proteins 0.000 description 1
• GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
• HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 108090000190 Thrombin Proteins 0.000 description 1
• 208000035317 Total hypoxanthine-guanine phosphoribosyl transferase deficiency Diseases 0.000 description 1
• 102100030798 Transcription factor HES-1 Human genes 0.000 description 1
• 108050000630 Transcription factor SOX-2 Proteins 0.000 description 1
• 101710101305 Transducin-like enhancer protein 1 Proteins 0.000 description 1
• 102100039362 Transducin-like enhancer protein 1 Human genes 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 description 1
• IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
• 102100031278 Undifferentiated embryonic cell transcription factor 1 Human genes 0.000 description 1
• 102000050488 Urotensin II Human genes 0.000 description 1
• 108010018369 Urotensin II Proteins 0.000 description 1
• 102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 241000700605 Viruses Species 0.000 description 1
• FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
• 229930003451 Vitamin B1 Natural products 0.000 description 1
• 229930003779 Vitamin B12 Natural products 0.000 description 1
• LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
• 229930003268 Vitamin C Natural products 0.000 description 1
• QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
• 108010031318 Vitronectin Proteins 0.000 description 1
• 102100035140 Vitronectin Human genes 0.000 description 1
• 101001029301 Xenopus tropicalis Forkhead box protein D3 Proteins 0.000 description 1
• IYOZTVGMEWJPKR-IJLUTSLNSA-N Y-27632 Chemical compound C1C[C@@H]([C@H](N)C)CC[C@@H]1C(=O)NC1=CC=NC=C1 IYOZTVGMEWJPKR-IJLUTSLNSA-N 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• 102100020919 Zinc finger and SCAN domain-containing protein 10 Human genes 0.000 description 1
• GVLOFRPVRYAFKI-VSGBNLITSA-N [(2R,5R)-2-benzyl-5-prop-2-ynoxypiperidin-1-yl]-[4-[bis(4-fluorophenyl)-hydroxymethyl]triazol-2-yl]methanone Chemical compound OC(c1cnn(n1)C(=O)N1C[C@@H](CC[C@@H]1Cc1ccccc1)OCC#C)(c1ccc(F)cc1)c1ccc(F)cc1 GVLOFRPVRYAFKI-VSGBNLITSA-N 0.000 description 1
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
• BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 description 1
• 229960000571 acetazolamide Drugs 0.000 description 1
• XJLATMLVMSFZBN-VYDXJSESSA-N actinonin Chemical compound CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO XJLATMLVMSFZBN-VYDXJSESSA-N 0.000 description 1
• XJLATMLVMSFZBN-UHFFFAOYSA-N actinonine Natural products CCCCCC(CC(=O)NO)C(=O)NC(C(C)C)C(=O)N1CCCC1CO XJLATMLVMSFZBN-UHFFFAOYSA-N 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 239000000488 activin Substances 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 229960005305 adenosine Drugs 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 229960003767 alanine Drugs 0.000 description 1
• 229960002648 alanylglutamine Drugs 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
• CJCSPKMFHVPWAR-JTQLQIEISA-N alpha-methyl-L-dopa Chemical compound OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 CJCSPKMFHVPWAR-JTQLQIEISA-N 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 239000001099 ammonium carbonate Substances 0.000 description 1
• 210000001691 amnion Anatomy 0.000 description 1
• 210000004381 amniotic fluid Anatomy 0.000 description 1
• 230000033115 angiogenesis Effects 0.000 description 1
• 229950006323 angiotensin ii Drugs 0.000 description 1
• 229940124339 anthelmintic agent Drugs 0.000 description 1
• 239000000921 anthelmintic agent Substances 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000003110 anti-inflammatory effect Effects 0.000 description 1
• 230000002141 anti-parasite Effects 0.000 description 1
• 230000000840 anti-viral effect Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 239000003096 antiparasitic agent Substances 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 229960005261 aspartic acid Drugs 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 229960001799 aurothioglucose Drugs 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 239000007640 basal medium Substances 0.000 description 1
• 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• BNQDCRGUHNALGH-UHFFFAOYSA-N benserazide Chemical compound OCC(N)C(=O)NNCC1=CC=C(O)C(O)=C1O BNQDCRGUHNALGH-UHFFFAOYSA-N 0.000 description 1
• 229960001335 benserazide hydrochloride Drugs 0.000 description 1
• LZCZIHQBSCVGRD-UHFFFAOYSA-N benzenecarboximidamide;hydron;chloride Chemical compound [Cl-].NC(=[NH2+])C1=CC=CC=C1 LZCZIHQBSCVGRD-UHFFFAOYSA-N 0.000 description 1
• 229960002537 betamethasone Drugs 0.000 description 1
• UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
• 230000000975 bioactive effect Effects 0.000 description 1
• 230000008238 biochemical pathway Effects 0.000 description 1
• 239000012620 biological material Substances 0.000 description 1
• 229960000074 biopharmaceutical Drugs 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• KQNZDYYTLMIZCT-KQPMLPITSA-N brefeldin A Chemical compound O[C@@H]1\C=C\C(=O)O[C@@H](C)CCC\C=C\[C@@H]2C[C@H](O)C[C@H]21 KQNZDYYTLMIZCT-KQPMLPITSA-N 0.000 description 1
• JUMGSHROWPPKFX-UHFFFAOYSA-N brefeldin-A Natural products CC1CCCC=CC2(C)CC(O)CC2(C)C(O)C=CC(=O)O1 JUMGSHROWPPKFX-UHFFFAOYSA-N 0.000 description 1
• 210000000621 bronchi Anatomy 0.000 description 1
• 229960004436 budesonide Drugs 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 230000003139 buffering effect Effects 0.000 description 1
• 230000009172 bursting Effects 0.000 description 1
• 229910052793 cadmium Inorganic materials 0.000 description 1
• BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
• QCUOBSQYDGUHHT-UHFFFAOYSA-L cadmium sulfate Chemical compound [Cd+2].[O-]S([O-])(=O)=O QCUOBSQYDGUHHT-UHFFFAOYSA-L 0.000 description 1
• 229910000369 cadmium(II) sulfate Inorganic materials 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 229930008399 cantharidic acid Natural products 0.000 description 1
• DHZBEENLJMYSHQ-XCVPVQRUSA-N cantharidin Chemical compound C([C@@H]1O2)C[C@@H]2[C@]2(C)[C@@]1(C)C(=O)OC2=O DHZBEENLJMYSHQ-XCVPVQRUSA-N 0.000 description 1
• 229940095758 cantharidin Drugs 0.000 description 1
• 229930008397 cantharidin Natural products 0.000 description 1
• DHZBEENLJMYSHQ-UHFFFAOYSA-N cantharidine Natural products O1C2CCC1C1(C)C2(C)C(=O)OC1=O DHZBEENLJMYSHQ-UHFFFAOYSA-N 0.000 description 1
• TZFNLOMSOLWIDK-JTQLQIEISA-N carbidopa (anhydrous) Chemical compound NN[C@@](C(O)=O)(C)CC1=CC=C(O)C(O)=C1 TZFNLOMSOLWIDK-JTQLQIEISA-N 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
• HOPSCVCBEOCPJZ-UHFFFAOYSA-N carboxymethyl(trimethyl)azanium;chloride Chemical class [Cl-].C[N+](C)(C)CC(O)=O HOPSCVCBEOCPJZ-UHFFFAOYSA-N 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 238000000525 cavity enhanced absorption spectroscopy Methods 0.000 description 1
• 238000010370 cell cloning Methods 0.000 description 1
• 230000011712 cell development Effects 0.000 description 1
• 230000022534 cell killing Effects 0.000 description 1
• 230000006037 cell lysis Effects 0.000 description 1
• 230000012292 cell migration Effects 0.000 description 1
• 230000009087 cell motility Effects 0.000 description 1
• 230000009134 cell regulation Effects 0.000 description 1
• 230000010307 cell transformation Effects 0.000 description 1
• 230000019522 cellular metabolic process Effects 0.000 description 1
• 230000005754 cellular signaling Effects 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• XAKAQCMEMMZUEO-UHFFFAOYSA-N chembl1256623 Chemical compound O=NN(C)C1=CC=C(O)C(O)=C1 XAKAQCMEMMZUEO-UHFFFAOYSA-N 0.000 description 1
• XRZYELWZLNAXGE-KPKJPENVSA-N chembl539947 Chemical compound CC(C)(C)C1=CC(\C=C(/C#N)C(N)=S)=CC(C(C)(C)C)=C1O XRZYELWZLNAXGE-KPKJPENVSA-N 0.000 description 1
• ZGHQGWOETPXKLY-XVNBXDOJSA-N chembl77030 Chemical compound NC(=S)C(\C#N)=C\C1=CC=C(O)C(O)=C1 ZGHQGWOETPXKLY-XVNBXDOJSA-N 0.000 description 1
• 238000001311 chemical methods and process Methods 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 229910052801 chlorine Inorganic materials 0.000 description 1
• 229960002155 chlorothiazide Drugs 0.000 description 1
• 210000003483 chromatin Anatomy 0.000 description 1
• 229910052804 chromium Inorganic materials 0.000 description 1
• 239000011651 chromium Substances 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 229960001265 ciclosporin Drugs 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 101150115304 cls-2 gene Proteins 0.000 description 1
• 101150058580 cls-3 gene Proteins 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 239000010941 cobalt Substances 0.000 description 1
• 229910017052 cobalt Inorganic materials 0.000 description 1
• GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
• AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
• OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
• 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
• OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
• 229960004544 cortisone Drugs 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 229960000978 cyproterone acetate Drugs 0.000 description 1
• UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 description 1
• 229960003067 cystine Drugs 0.000 description 1
• 210000000172 cytosol Anatomy 0.000 description 1
• 229960003710 dantrolene sodium Drugs 0.000 description 1
• LTWQNYPDAUSXBC-CDJGKPBYSA-L dantrolene sodium hemiheptahydrate Chemical compound O.O.O.O.O.O.O.[Na+].[Na+].C1=CC([N+](=O)[O-])=CC=C1C(O1)=CC=C1\C=N\N1C(=O)[N-]C(=O)C1.C1=CC([N+](=O)[O-])=CC=C1C(O1)=CC=C1\C=N\N1C(=O)[N-]C(=O)C1 LTWQNYPDAUSXBC-CDJGKPBYSA-L 0.000 description 1
• YBGKGTOOPNQOKH-UHFFFAOYSA-N daphnetin Natural products OC1=CC=CC2=C1OC(=O)C=C2O YBGKGTOOPNQOKH-UHFFFAOYSA-N 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
• 230000000779 depleting effect Effects 0.000 description 1
• 229960001378 dequalinium chloride Drugs 0.000 description 1
• 238000009795 derivation Methods 0.000 description 1
• 108700001680 des-(1-3)- insulin-like growth factor 1 Proteins 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 230000006866 deterioration Effects 0.000 description 1
• 230000001627 detrimental effect Effects 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 238000009792 diffusion process Methods 0.000 description 1
• WFTCFVUQORELJZ-USHJOAKVSA-L disodium;(2s)-2-amino-3-(4-oxidophenyl)propanoate;dihydrate Chemical compound O.O.[Na+].[Na+].[O-]C(=O)[C@@H](N)CC1=CC=C([O-])C=C1 WFTCFVUQORELJZ-USHJOAKVSA-L 0.000 description 1
• OQKHVXFOYFBMDJ-ODIUWQMJSA-L disodium;(2s)-3-(1h-indol-3-yl)-2-[[(2s)-4-methyl-2-[[oxido-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyphosphoryl]amino]pentanoyl]amino]propanoate Chemical compound [Na+].[Na+].N([C@@H](CC(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C([O-])=O)P([O-])(=O)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O OQKHVXFOYFBMDJ-ODIUWQMJSA-L 0.000 description 1
• 108010007093 dispase Proteins 0.000 description 1
• FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 description 1
• 229960001253 domperidone Drugs 0.000 description 1
• 229960003638 dopamine Drugs 0.000 description 1
• 230000003828 downregulation Effects 0.000 description 1
• 238000007876 drug discovery Methods 0.000 description 1
• 210000001198 duodenum Anatomy 0.000 description 1
• 210000003981 ectoderm Anatomy 0.000 description 1
• 210000001705 ectoderm cell Anatomy 0.000 description 1
• 230000002900 effect on cell Effects 0.000 description 1
• 230000000487 effect on differentiation Effects 0.000 description 1
• 229960002694 emetine Drugs 0.000 description 1
• VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
• RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
• 238000005265 energy consumption Methods 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 238000006911 enzymatic reaction Methods 0.000 description 1
• 210000001339 epidermal cell Anatomy 0.000 description 1
• 229940116977 epidermal growth factor Drugs 0.000 description 1
• YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 description 1
• 230000007705 epithelial mesenchymal transition Effects 0.000 description 1
• 235000004626 essential fatty acids Nutrition 0.000 description 1
• 230000032050 esterification Effects 0.000 description 1
• 238000005886 esterification reaction Methods 0.000 description 1
• 229960005309 estradiol Drugs 0.000 description 1
• 229960003399 estrone Drugs 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 210000002388 eustachian tube Anatomy 0.000 description 1
• 230000003203 everyday effect Effects 0.000 description 1
• 238000010195 expression analysis Methods 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 229960002435 fasudil Drugs 0.000 description 1
• LFVPBERIVUNMGV-UHFFFAOYSA-N fasudil hydrochloride Chemical compound Cl.C=1C=CC2=CN=CC=C2C=1S(=O)(=O)N1CCCNCC1 LFVPBERIVUNMGV-UHFFFAOYSA-N 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 238000000855 fermentation Methods 0.000 description 1
• 230000004151 fermentation Effects 0.000 description 1
• 229960002413 ferric citrate Drugs 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 229930003935 flavonoid Natural products 0.000 description 1
• 150000002215 flavonoids Chemical class 0.000 description 1
• 235000017173 flavonoids Nutrition 0.000 description 1
• 238000007667 floating Methods 0.000 description 1
• 229960002074 flutamide Drugs 0.000 description 1
• MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
• OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 description 1
• 229960002258 fulvestrant Drugs 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 230000007045 gastrulation Effects 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 230000009368 gene silencing by RNA Effects 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 229940045109 genistein Drugs 0.000 description 1
• 235000006539 genistein Nutrition 0.000 description 1
• TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
• ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
• 229910052732 germanium Inorganic materials 0.000 description 1
• GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
• 210000001434 ghrelin secreting cell Anatomy 0.000 description 1
• 210000001511 glucagon-secreting cell Anatomy 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 229960002989 glutamic acid Drugs 0.000 description 1
• 229960002449 glycine Drugs 0.000 description 1
• 230000002414 glycolytic effect Effects 0.000 description 1
• 235000009424 haa Nutrition 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 125000000623 heterocyclic group Chemical group 0.000 description 1
• SGJNQVTUYXCBKH-HNQUOIGGSA-N hispidin Chemical compound O1C(=O)C=C(O)C=C1\C=C\C1=CC=C(O)C(O)=C1 SGJNQVTUYXCBKH-HNQUOIGGSA-N 0.000 description 1
• SGJNQVTUYXCBKH-UHFFFAOYSA-N hispidin Natural products O1C(=O)C=C(O)C=C1C=CC1=CC=C(O)C(O)=C1 SGJNQVTUYXCBKH-UHFFFAOYSA-N 0.000 description 1
• 229960001340 histamine Drugs 0.000 description 1
• 229960002885 histidine Drugs 0.000 description 1
• 230000003054 hormonal effect Effects 0.000 description 1
• 102000055647 human CSF2RB Human genes 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 229960002003 hydrochlorothiazide Drugs 0.000 description 1
• 229960000890 hydrocortisone Drugs 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
• 230000002102 hyperpolarization Effects 0.000 description 1
• 229960002491 ibudilast Drugs 0.000 description 1
• 229950000254 imazodan Drugs 0.000 description 1
• 230000002519 immonomodulatory effect Effects 0.000 description 1
• 238000012760 immunocytochemical staining Methods 0.000 description 1
• 230000002055 immunohistochemical effect Effects 0.000 description 1
• 238000012744 immunostaining Methods 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 238000007901 in situ hybridization Methods 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 230000036512 infertility Effects 0.000 description 1
• 231100000535 infertility Toxicity 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 229910001410 inorganic ion Inorganic materials 0.000 description 1
• 102000028416 insulin-like growth factor binding Human genes 0.000 description 1
• 108091022911 insulin-like growth factor binding Proteins 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
• NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
• 230000002427 irreversible effect Effects 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
• AZSNMRSAGSSBNP-ZGXOMDHGSA-N ivermectin Chemical compound C1C[C@H](C)[C@@H]([C@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 AZSNMRSAGSSBNP-ZGXOMDHGSA-N 0.000 description 1
• CLEXYFLHGFJONT-UHFFFAOYSA-N jervine Natural products C1C=C2CC(O)CCC2(C)C(C(=O)C2=C3C)C1C2CCC13OC2CC(C)CNC2C1C CLEXYFLHGFJONT-UHFFFAOYSA-N 0.000 description 1
• QRXOCOSLDOPPKH-UHFFFAOYSA-N jervine sulfate Natural products CC1CNC2C(C1)OC3(CCC4=C(C3C)C(=O)C5C4CC=C6CC(O)CCC56C)C2C QRXOCOSLDOPPKH-UHFFFAOYSA-N 0.000 description 1
• QQUXFYAWXPMDOE-UHFFFAOYSA-N kenpaullone Chemical compound C1C(=O)NC2=CC=CC=C2C2=C1C1=CC(Br)=CC=C1N2 QQUXFYAWXPMDOE-UHFFFAOYSA-N 0.000 description 1
• 210000003292 kidney cell Anatomy 0.000 description 1
• 150000002596 lactones Chemical class 0.000 description 1
• 150000002605 large molecules Chemical class 0.000 description 1
• 238000011031 large-scale manufacturing process Methods 0.000 description 1
• 229960002162 lercanidipine hydrochloride Drugs 0.000 description 1
• 229960003136 leucine Drugs 0.000 description 1
• 150000002617 leukotrienes Chemical class 0.000 description 1
• 229960001614 levamisole Drugs 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 210000005229 liver cell Anatomy 0.000 description 1
• 210000005228 liver tissue Anatomy 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 239000001095 magnesium carbonate Substances 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
• 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
• 229960003951 masoprocol Drugs 0.000 description 1
• PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 description 1
• 229960003987 melatonin Drugs 0.000 description 1
• DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
• 229960000901 mepacrine Drugs 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 239000002207 metabolite Substances 0.000 description 1
• 230000031864 metaphase Effects 0.000 description 1
• 229960004452 methionine Drugs 0.000 description 1
• ZZDBMDNRQQDSKG-UHFFFAOYSA-N methyl 5-bromo-1-benzofuran-2-carboxylate Chemical compound BrC1=CC=C2OC(C(=O)OC)=CC2=C1 ZZDBMDNRQQDSKG-UHFFFAOYSA-N 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 229960002439 mibefradil dihydrochloride Drugs 0.000 description 1
• VKHAHZOOUSRJNA-GCNJZUOMSA-N mifepristone Chemical compound C1([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=CC=C(N(C)C)C=C1 VKHAHZOOUSRJNA-GCNJZUOMSA-N 0.000 description 1
• 229960003248 mifepristone Drugs 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• PZRHRDRVRGEVNW-UHFFFAOYSA-N milrinone Chemical compound N1C(=O)C(C#N)=CC(C=2C=CN=CC=2)=C1C PZRHRDRVRGEVNW-UHFFFAOYSA-N 0.000 description 1
• 229960003574 milrinone Drugs 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 231100000324 minimal toxicity Toxicity 0.000 description 1
• 239000003226 mitogen Substances 0.000 description 1
• VLAPMBHFAWRUQP-UHFFFAOYSA-L molybdic acid Chemical compound O[Mo](O)(=O)=O VLAPMBHFAWRUQP-UHFFFAOYSA-L 0.000 description 1
• 230000000877 morphologic effect Effects 0.000 description 1
• 210000003205 muscle Anatomy 0.000 description 1
• 210000000107 myocyte Anatomy 0.000 description 1
• PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
• 229940116852 myricetin Drugs 0.000 description 1
• 235000007743 myricetin Nutrition 0.000 description 1
• DTPSXFMGMQOVTG-ISJGIBHGSA-N n-[(2r)-4-[3-[(1s,2r)-2-aminocyclopropyl]phenoxy]-1-(benzylamino)-1-oxobutan-2-yl]benzamide Chemical compound N[C@@H]1C[C@H]1C1=CC=CC(OCC[C@@H](NC(=O)C=2C=CC=CC=2)C(=O)NCC=2C=CC=CC=2)=C1 DTPSXFMGMQOVTG-ISJGIBHGSA-N 0.000 description 1
• QTCFYQHZJIIHBS-UHFFFAOYSA-N n-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]-3-nitrobenzamide Chemical compound [O-][N+](=O)C1=CC=CC(C(=O)NC=2N(C3=CC=CC=C3N=2)CCN2CCOCC2)=C1 QTCFYQHZJIIHBS-UHFFFAOYSA-N 0.000 description 1
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
• WDISRLXRMMTXEV-UHFFFAOYSA-N n-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide;hydron;chloride Chemical compound Cl.COC1=CC(NS(C)(=O)=O)=CC=C1NC1=C(C=CC=C2)C2=NC2=CC=CC=C12 WDISRLXRMMTXEV-UHFFFAOYSA-N 0.000 description 1
• NGZYRKGJWYJGRS-UHFFFAOYSA-N n-methylpyrrolidin-3-amine Chemical compound CNC1CCNC1 NGZYRKGJWYJGRS-UHFFFAOYSA-N 0.000 description 1
• 201000004931 neurofibromatosis Diseases 0.000 description 1
• 230000003472 neutralizing effect Effects 0.000 description 1
• LGQLOGILCSXPEA-UHFFFAOYSA-L nickel sulfate Chemical compound [Ni+2].[O-]S([O-])(=O)=O LGQLOGILCSXPEA-UHFFFAOYSA-L 0.000 description 1
• 229910000363 nickel(II) sulfate Inorganic materials 0.000 description 1
• 108010008217 nidogen Proteins 0.000 description 1
• 229960002653 nilutamide Drugs 0.000 description 1
• XWXYUMMDTVBTOU-UHFFFAOYSA-N nilutamide Chemical compound O=C1C(C)(C)NC(=O)N1C1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 XWXYUMMDTVBTOU-UHFFFAOYSA-N 0.000 description 1
• 229960002748 norepinephrine Drugs 0.000 description 1
• SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 229920001778 nylon Polymers 0.000 description 1
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
• GTVPOLSIJWJJNY-UHFFFAOYSA-N olomoucine Chemical compound N1=C(NCCO)N=C2N(C)C=NC2=C1NCC1=CC=CC=C1 GTVPOLSIJWJJNY-UHFFFAOYSA-N 0.000 description 1
• 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
• 229940012843 omega-3 fatty acid Drugs 0.000 description 1
• 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
• 229940033080 omega-6 fatty acid Drugs 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
• 229960003343 ouabain Drugs 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 238000006213 oxygenation reaction Methods 0.000 description 1
• 210000002685 pancreatic polypeptide-secreting cell Anatomy 0.000 description 1
• 229960003207 papaverine hydrochloride Drugs 0.000 description 1
• 230000000849 parathyroid Effects 0.000 description 1
• XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
• 229960004448 pentamidine Drugs 0.000 description 1
• XDRYMKDFEDOLFX-UHFFFAOYSA-N pentamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 XDRYMKDFEDOLFX-UHFFFAOYSA-N 0.000 description 1
• 229960001624 pentamidine isethionate Drugs 0.000 description 1
• YBVNFKZSMZGRAD-UHFFFAOYSA-N pentamidine isethionate Chemical compound OCCS(O)(=O)=O.OCCS(O)(=O)=O.C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 YBVNFKZSMZGRAD-UHFFFAOYSA-N 0.000 description 1
• 229960003330 pentetic acid Drugs 0.000 description 1
• 229960001476 pentoxifylline Drugs 0.000 description 1
• 239000000813 peptide hormone Substances 0.000 description 1
• 239000000816 peptidomimetic Substances 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 230000035699 permeability Effects 0.000 description 1
• 230000002688 persistence Effects 0.000 description 1
• 230000002085 persistent effect Effects 0.000 description 1
• 238000002823 phage display Methods 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 210000003800 pharynx Anatomy 0.000 description 1
• PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 235000019175 phylloquinone Nutrition 0.000 description 1
• 239000011772 phylloquinone Substances 0.000 description 1
• SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
• MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
• PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 229960001898 phytomenadione Drugs 0.000 description 1
• 230000003169 placental effect Effects 0.000 description 1
• YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 1
• 229960001237 podophyllotoxin Drugs 0.000 description 1
• YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 description 1
• 239000004626 polylactic acid Substances 0.000 description 1
• 229920000656 polylysine Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 102000040430 polynucleotide Human genes 0.000 description 1
• 108091033319 polynucleotide Proteins 0.000 description 1
• 239000002157 polynucleotide Substances 0.000 description 1
• 108010055896 polyornithine Proteins 0.000 description 1
• 229920002714 polyornithine Polymers 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 238000004321 preservation Methods 0.000 description 1
• 230000003405 preventing effect Effects 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 239000000186 progesterone Substances 0.000 description 1
• 229960003387 progesterone Drugs 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 1
• 229950003776 protoporphyrin Drugs 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 150000003212 purines Chemical class 0.000 description 1
• PMXCMJLOPOFPBT-HNNXBMFYSA-N purvalanol A Chemical compound C=12N=CN(C(C)C)C2=NC(N[C@@H](CO)C(C)C)=NC=1NC1=CC=CC(Cl)=C1 PMXCMJLOPOFPBT-HNNXBMFYSA-N 0.000 description 1
• RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
• ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
• 150000003230 pyrimidines Chemical class 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 229960002119 raloxifene hydrochloride Drugs 0.000 description 1
• BKXVVCILCIUCLG-UHFFFAOYSA-N raloxifene hydrochloride Chemical compound [H+].[Cl-].C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 BKXVVCILCIUCLG-UHFFFAOYSA-N 0.000 description 1
• JAABVEXCGCXWRR-FBXFSONDSA-N rel-norcantharidin Chemical compound C1C[C@H]2[C@@H]3C(=O)OC(=O)[C@@H]3[C@@H]1O2 JAABVEXCGCXWRR-FBXFSONDSA-N 0.000 description 1
• 238000009256 replacement therapy Methods 0.000 description 1
• 230000001850 reproductive effect Effects 0.000 description 1
• 230000009933 reproductive health Effects 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 230000002207 retinal effect Effects 0.000 description 1
• 108090000064 retinoic acid receptors Proteins 0.000 description 1
• 102000003702 retinoic acid receptors Human genes 0.000 description 1
• 238000003757 reverse transcription PCR Methods 0.000 description 1
• 108091092562 ribozyme Proteins 0.000 description 1
• DEZFNHCVIZBHBI-ZHACJKMWSA-N rottlerin Chemical compound CC(=O)C1=C(O)C(C)=C(O)C(CC=2C(=C(C(=O)\C=C\C=3C=CC=CC=3)C=3OC(C)(C)C=CC=3C=2O)O)=C1O DEZFNHCVIZBHBI-ZHACJKMWSA-N 0.000 description 1
• 102200143689 rs121434227 Human genes 0.000 description 1
• 239000012266 salt solution Substances 0.000 description 1
• 229940125944 selective estrogen receptor degrader Drugs 0.000 description 1
• 229940082569 selenite Drugs 0.000 description 1
• MCAHWIHFGHIESP-UHFFFAOYSA-L selenite(2-) Chemical compound [O-][Se]([O-])=O MCAHWIHFGHIESP-UHFFFAOYSA-L 0.000 description 1
• BTIHMVBBUGXLCJ-OAHLLOKOSA-N seliciclib Chemical compound C=12N=CN(C(C)C)C2=NC(N[C@@H](CO)CC)=NC=1NCC1=CC=CC=C1 BTIHMVBBUGXLCJ-OAHLLOKOSA-N 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 229960001153 serine Drugs 0.000 description 1
• 230000000405 serological effect Effects 0.000 description 1
• 239000012679 serum free medium Substances 0.000 description 1
• 208000007056 sickle cell anemia Diseases 0.000 description 1
• 239000002356 single layer Substances 0.000 description 1
• 230000016160 smooth muscle contraction Effects 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 235000019795 sodium metasilicate Nutrition 0.000 description 1
• 229910052911 sodium silicate Inorganic materials 0.000 description 1
• XBTIPIZROJAKOJ-UHFFFAOYSA-M sodium;5-(pyridin-3-ylmethyl)-1-benzofuran-2-carboxylate Chemical compound [Na+].C=1C=C2OC(C(=O)[O-])=CC2=CC=1CC1=CC=CN=C1 XBTIPIZROJAKOJ-UHFFFAOYSA-M 0.000 description 1
• 238000010374 somatic cell nuclear transfer Methods 0.000 description 1
• NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
• 229960000553 somatostatin Drugs 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• OTKJDMGTUTTYMP-ZWKOTPCHSA-N sphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO OTKJDMGTUTTYMP-ZWKOTPCHSA-N 0.000 description 1
• LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
• 229960002256 spironolactone Drugs 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 230000007480 spreading Effects 0.000 description 1
• 238000003892 spreading Methods 0.000 description 1
• 102000009076 src-Family Kinases Human genes 0.000 description 1
• 108010087686 src-Family Kinases Proteins 0.000 description 1
• 229910001220 stainless steel Inorganic materials 0.000 description 1
• 239000010935 stainless steel Substances 0.000 description 1
• 150000003432 sterols Chemical class 0.000 description 1
• 235000003702 sterols Nutrition 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 210000002536 stromal cell Anatomy 0.000 description 1
• 229940035673 stromectol Drugs 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 230000001360 synchronised effect Effects 0.000 description 1
• 108060008037 tachykinin Proteins 0.000 description 1
• FQZYTYWMLGAPFJ-OQKDUQJOSA-N tamoxifen citrate Chemical compound [H+].[H+].[H+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 FQZYTYWMLGAPFJ-OQKDUQJOSA-N 0.000 description 1
• 229960003454 tamoxifen citrate Drugs 0.000 description 1
• 229960000351 terfenadine Drugs 0.000 description 1
• 150000003505 terpenes Chemical class 0.000 description 1
• IXFPJGBNCFXKPI-FSIHEZPISA-N thapsigargin Chemical compound CCCC(=O)O[C@H]1C[C@](C)(OC(C)=O)[C@H]2[C@H](OC(=O)CCCCCCC)[C@@H](OC(=O)C(\C)=C/C)C(C)=C2[C@@H]2OC(=O)[C@@](C)(O)[C@]21O IXFPJGBNCFXKPI-FSIHEZPISA-N 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 238000011285 therapeutic regimen Methods 0.000 description 1
• 229960003495 thiamine Drugs 0.000 description 1
• DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
• 229960002898 threonine Drugs 0.000 description 1
• 229960004072 thrombin Drugs 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 239000003104 tissue culture media Substances 0.000 description 1
• OUDSBRTVNLOZBN-UHFFFAOYSA-N tolazamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NN1CCCCCC1 OUDSBRTVNLOZBN-UHFFFAOYSA-N 0.000 description 1
• 229960002277 tolazamide Drugs 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 238000013518 transcription Methods 0.000 description 1
• 230000035897 transcription Effects 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 238000010361 transduction Methods 0.000 description 1
• 230000026683 transduction Effects 0.000 description 1
• 230000010474 transient expression Effects 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 229960005294 triamcinolone Drugs 0.000 description 1
• GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
• KOAVUYZAVMEAFA-ABCHLGSSSA-N triazanium;[[(2s,3s,5s)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2r,3r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate Chemical compound [NH4+].[NH4+].[NH4+].C1=NC2=C(N)N=CN=C2N1[C@@H](C(O)[C@H]1O)O[C@@H]1COP([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP(O)(=O)OC[C@@H]([C@@H](O)C1O)O[C@@H]1N1C(N=CN=C2N)=C2N=C1 KOAVUYZAVMEAFA-ABCHLGSSSA-N 0.000 description 1
• 238000001665 trituration Methods 0.000 description 1
• UOHFCPXBKJPCAD-UHFFFAOYSA-N tyrphostin 1 Chemical compound COC1=CC=C(C=C(C#N)C#N)C=C1 UOHFCPXBKJPCAD-UHFFFAOYSA-N 0.000 description 1
• GFNNBHLJANVSQV-UHFFFAOYSA-N tyrphostin AG 1478 Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1NC1=CC=CC(Cl)=C1 GFNNBHLJANVSQV-UHFFFAOYSA-N 0.000 description 1
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
• HFNHAPQMXICKCF-USJMABIRSA-N urotensin-ii Chemical compound N([C@@H](CC(O)=O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@@H](C(C)C)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CCC(O)=O)[C@@H](C)O HFNHAPQMXICKCF-USJMABIRSA-N 0.000 description 1
• KDQAABAKXDWYSZ-PNYVAJAMSA-N vinblastine sulfate Chemical class OS(O)(=O)=O.C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 KDQAABAKXDWYSZ-PNYVAJAMSA-N 0.000 description 1
• 235000010374 vitamin B1 Nutrition 0.000 description 1
• 239000011691 vitamin B1 Substances 0.000 description 1
• 235000019163 vitamin B12 Nutrition 0.000 description 1
• 239000011715 vitamin B12 Substances 0.000 description 1
• 235000019158 vitamin B6 Nutrition 0.000 description 1
• 239000011726 vitamin B6 Substances 0.000 description 1
• 235000019154 vitamin C Nutrition 0.000 description 1
• 239000011718 vitamin C Substances 0.000 description 1
• QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
• 235000005282 vitamin D3 Nutrition 0.000 description 1
• 239000011647 vitamin D3 Substances 0.000 description 1
• 229940045997 vitamin a Drugs 0.000 description 1
• 229940011671 vitamin b6 Drugs 0.000 description 1
• 229940021056 vitamin d3 Drugs 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 229940102001 zinc bromide Drugs 0.000 description 1
• 239000011592 zinc chloride Substances 0.000 description 1
• 235000005074 zinc chloride Nutrition 0.000 description 1
• 229960001763 zinc sulfate Drugs 0.000 description 1
• 239000011686 zinc sulphate Substances 0.000 description 1
• 235000009529 zinc sulphate Nutrition 0.000 description 1
• DTOSIQBPPRVQHS-UHFFFAOYSA-N α-Linolenic acid Chemical compound CCC=CCC=CCC=CCCCCCCCC(O)=O DTOSIQBPPRVQHS-UHFFFAOYSA-N 0.000 description 1